Patent Grant
8178541
The present invention relates to compounds having valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
The present invention relates to new substituted xanthines of general formula
the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV), the preparation thereof, the use thereof for the prevention or treatment of diseases or conditions associated with an increased DPP-IV activity or capable of being prevented or alleviated by reducing the DPP-IV activity, particularly type I or type II diabetes mellitus, the pharmaceutical compositions containing a compound of general formula (I) or a physiologically acceptable salt thereof as well as processes for the preparation thereof.
In the above formula I
The carboxy groups mentioned in the definition of the above mentioned groups may be replaced by a group which can be converted into a carboxy group in vivo or by a group which is negatively charged under physiological conditions,
Compounds which contain a group that can be cleaved in vivo are prodrugs of the corresponding compounds wherein this group that can be cleaved in vivo has been cleaved.
By a group which can be converted in vivo into a carboxy group is meant, for example, a hydroxymethyl group, a carboxy group esterified with an alcohol wherein the alcohol moiety is preferably a C1-6-alkanol, a phenyl-C1-3-alkanol, a C3-9-cycloalkanol, while a C5-8-cycloalkanol may additionally be substituted by one or two C1-3-alkyl groups, a C5-8-cycloalkanol wherein a methylene group in the 3 or 4 position is replaced by an oxygen atom or by an imino group optionally substituted by a C1-3-alkyl, phenyl-C1-3-alkyl, phenyl-C1-3-alkyloxycarbonyl or C2-6-alkanoyl group and the cycloalkanol moiety may additionally be substituted by one or two C1-3-alkyl groups, a C4-7-cycloalkenol, a C3-5-alkenol, a phenyl-C3-5-alkenol, a C3-5-alkynol or phenyl-C3-5-alkynol with the proviso that no bonds to the oxygen atom start from a carbon atom which carries a double or triple bond, a C3-8-cycloalkyl-C1-3-alkanol, a bicycloalkanol with a total of 8 to 10 carbon atoms which may additionally be substituted in the bicycloalkyl moiety by one or two C1-3-alkyl groups, a 1,3-dihydro-3-oxo-1-isobenzofuranol or an alcohol of formula
Rp—CO—O—(RqCRr)—OH,
wherein
A first object of the invention relates to compounds of general formula (I) wherein
A first preferred sub-group of the first object of the invention comprises compounds of general formula I wherein
A second preferred sub-group of the first object of the invention comprises compounds of general formula I, wherein
A third preferred sub-group of the first object of the invention comprises compounds of general formula I according to claim 1, wherein
A second object of the invention relates to compounds of general formula I, wherein
A preferred sub-group of the second object of the invention comprises compounds of general formula I wherein
A particularly preferred sub-group of the second object of the invention comprises compounds of general formula I wherein
A second preferred sub-group of the second object of the invention comprises compounds of general formula I, wherein R1 and R2 are defined as immediately above and R3 denotes a 1-buten-1-yl group,
A third preferred sub-group of the second object of the invention comprises compounds of general formula I wherein R1 and R2 are defined as immediately above and R3 denotes a 2-buten-1-yl group,
A fourth preferred sub-group of the second object of the invention comprises compounds of general formula I wherein R1 and R2 are defined as immediately above and R3 denotes a 2-butyn-1-yl group,
A third object of the invention relates to compounds of general formula I wherein
A first preferred sub-group of the third object of the invention comprises compounds of general formula I wherein
A second preferred sub-group of the third object of the invention comprises compounds of general formula I wherein R1 and R2 are as hereinbefore defined and R3 denotes a 2-chlorobenzyl group, the tautomers, enantiomers, diastereomers, the mixtures thereof and the salts thereof.
A third preferred sub-group of the third object of the invention comprises compounds of general formula I wherein R1 and R2 are as hereinbefore defined and R3 denotes a 2-bromobenzyl group, the tautomers, enantiomers, diastereomers, the mixtures thereof and the salts thereof.
A fourth preferred sub-group of the third object of the invention comprises compounds of general formula I wherein R1 and R2 are as hereinbefore defined and R3 denotes a 2-ethynylbenzyl group, the tautomers, enantiomers, diastereomers, the mixtures thereof and the salts thereof.
A fifth preferred sub-group of the third object of the invention comprises compounds of general formula I wherein R1 and R2 are as hereinbefore defined and R3 denotes a 2-cyanobenzyl group, the tautomers, enantiomers, diastereomers, the mixtures thereof and the salts thereof.
Most particularly preferred are the following compounds of general formula I:
According to the invention the compounds of general formula I are obtained by methods known per se, for example by the following methods:
wherein
The reaction is expediently carried out in a solvent such as isopropanol, butanol, tetrahydrofuran, dioxane, dimethylformamide, dimethylsulphoxide, ethyleneglycol monomethylether, ethyleneglycol diethylether or sulpholane, optionally in the presence of an inorganic or tertiary organic base, e.g. sodium carbonate, potassium carbonate or potassium hydroxide, a tertiary organic base, e.g. triethylamine, or in the presence of N-ethyl-diisopropylamine (Hünig base), while these organic bases may simultaneously also serve as solvent, and optionally in the presence of a reaction accelerator such as an alkali metal halide or a palladium-based catalyst at temperatures between −20 and 180° C., but preferably at temperatures between −10 and 120° C. The reaction may, however, also be carried out without a solvent or in an excess of the 3-aminopiperidine.
wherein R1, R2 and R3 are as hereinbefore defined.
The tert.-butyloxycarbonyl group is preferably cleaved by treatment with an acid such as trifluoroacetic acid or hydrochloric acid or by treatment with bromotrimethylsilane or iodotrimethylsilane, optionally using a solvent such as methylene chloride, ethyl acetate, dioxane, methanol, isopropanol or diethyl ether at temperatures between 0 and 80° C.
wherein R2 and R3 are as hereinbefore defined and R1′ contains a carboxy group protected by a C1-4-alkyl group.
The protecting group is cleaved by hydrolysis, for example, using an acid such as hydrochloric acid or sulphuric acid or an alkali metal hydroxide such as lithium hydroxide, sodium hydroxide or potassium hydroxide in a solvent such as methanol, ethanol, isopropanol, tetrahydrofuran or dioxane in the presence of water.
In the reactions described hereinbefore, any reactive groups present such as carboxy, amino, alkylamino or imino groups may be protected during the reaction by conventional protecting groups which are cleaved again after the reaction.
For example, a protecting group for a carboxy group may be a trimethylsilyl, methyl, ethyl, tert.butyl, benzyl or tetrahydropyranyl group and
Any protecting group used is optionally subsequently cleaved for example by hydrolysis in an aqueous solvent, e.g. in water, isopropanol/water, acetic acid/water, tetrahydrofuran/water or dioxane/water, in the presence of an acid such as trifluoroacetic acid, hydrochloric acid or sulphuric acid or in the presence of an alkali metal base such as sodium hydroxide or potassium hydroxide or aprotically, e.g. in the presence of iodotrimethylsilane, at temperatures between 0 and 120° C., preferably at temperatures between 10 and 100° C.
However, a benzyl, methoxybenzyl or benzyloxycarbonyl group is cleaved, for example, hydrogenolytically, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal in a suitable solvent such as methanol, ethanol, ethyl acetate or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid at temperatures between 0 and 100° C., but preferably at temperatures between 20 and 60° C., and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to 5 bar. A 2,4-dimethoxybenzyl group, however, is preferably cleaved in trifluoroacetic acid in the presence of anisol.
A tert.butyl or tert.butyloxycarbonyl group is preferably cleaved by treating with an acid such as trifluoroacetic acid or hydrochloric acid or by treating with iodotrimethylsilane, optionally using a solvent such as methylene chloride, dioxan, methanol or diethylether.
A trifluoroacetyl group is preferably cleaved by treating with an acid such as hydrochloric acid, optionally in the presence of a solvent such as acetic acid at temperatures between 50 and 120° C., or by treating with sodium hydroxide solution, optionally in the presence of a solvent such as tetrahydrofuran at temperatures between 0 and 50° C.
A phthalyl group is preferably cleaved in the presence of hydrazine or a primary amine such as methylamine, ethylamine or n-butylamine in a solvent such as methanol, ethanol, isopropanol, toluene/water or dioxan at temperatures between 20 and 50° C.
Moreover, the compounds of general formula I obtained may be resolved into their enantiomers and/or diastereomers, as mentioned hereinbefore. Thus, for example, cis/trans mixtures may be resolved into their cis and trans isomers, and compounds with at least one optically active carbon atom may be separated into their enantiomers.
Thus, for example, the cis/trans mixtures may be resolved by chromatography into the cis and trans isomers thereof, the compounds of general formula I obtained which occur as racemates may be separated by methods known per se (cf. Allinger N. L. and Eliel E. L. in “Topics in Stereochemistry”, Vol. 6, Wiley Interscience, 1971) into their optical antipodes and compounds of general formula I with at least 2 asymmetric carbon atoms may be resolved into their diastereomers on the basis of their physical-chemical differences using methods known per se, e.g. by chromatography and/or fractional crystallisation, and, if these compounds are obtained in racemic form, they may subsequently be resolved into the enantiomers as mentioned above.
The enantiomers are preferably separated by column separation on chiral phases or by recrystallisation from an optically active solvent or by reacting with an optically active substance which forms salts or derivatives such as e.g. esters or amides with the racemic compound, particularly acids and the activated derivatives or alcohols thereof, and separating the diastereomeric mixture of salts or derivatives thus obtained, e.g. on the basis of their differences in solubility, whilst the free antipodes may be released from the pure diastereomeric salts or derivatives by the action of suitable agents. Optically active acids in common use are e.g. the D- and L-forms of tartaric acid or dibenzoyltartaric acid, di-o-tolyltartaric acid, malic acid, mandelic acid, camphorsulphonic acid, glutamic acid, aspartic acid or quinic acid. An optically active alcohol may be for example (+) or (−)-menthol and an optically active acyl group in amides, for example, may be a (+)- or (−)-menthyloxycarbonyl.
Furthermore, the compounds of formula I may be converted into the salts thereof, particularly for pharmaceutical use into the physiologically acceptable salts with inorganic or organic acids. Acids which may be used for this purpose include for example hydrochloric acid, hydrobromic acid, sulphuric acid, phosphoric acid, fumaric acid, succinic acid, lactic acid, citric acid, tartaric acid or maleic acid.
Moreover, if the new compounds of formula I thus obtained contain a carboxy group, they may subsequently, if desired, be converted into the salts thereof with inorganic or organic bases, particularly for pharmaceutical use into the physiologically acceptable salts thereof. Suitable bases for this purpose include for example sodium hydroxide, potassium hydroxide, arginine, cyclohexylamine, ethanolamine, diethanolamine and triethanolamine.
The compounds of general formulae II to IV used as starting materials are either known from the literature or may be obtained by methods known from the literature (cf. Examples I to LXXI).
As already mentioned hereinbefore, the compounds of general formula I according to the invention and the physiologically acceptable salts thereof have valuable pharmacological properties, particularly an inhibiting effect on the enzyme DPP-IV.
The biological properties of the new compounds were investigated as follows:
The ability of the substances and their corresponding salts to inhibit the DPP-IV activity can be demonstrated in a test set-up in which an extract of human colon carcinoma cell line Caco-2 is used as the DPP-IV source. The differentiation of the cells in order to induce the DPP-IV expression was carried out as described by Reiher et al. in an article entitled “Increased expression of intestinal cell line Caco-2”, which appeared in Proc. Natl. Acad. Sci. Vol. 90, pages 5757-5761 (1993). The cell extract was obtained from cells solubilised in a buffer (10 mM Tris HCl, 0.15 M NaCl, 0.04 t.i.u. aprotinin, 0.5% Nonidet-P40, pH 8.0) by centrifuging at 35,000 g of for 30 minutes at 4° C. (to remove cell debris).
The DPP-IV assay was carried out as follows:
50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added. The potency of the test substances in question, expressed as IC50 values, was calculated from dosage/activity curves consisting of 11 measuring points in each case. The following results were obtained:
The compounds prepared according to the invention are well tolerated, as for example when 10 mg/kg of the compound of Example 2(80) were administered to rats by oral route no changes in the animals' behaviour could be detected.
In view of their ability to inhibit DPP-IV activity, the compounds of general formula I according to the invention and the corresponding pharmaceutically acceptable salts thereof are suitable for treating all those conditions or illnesses which can be influenced by the inhibition of the DPP-IV activity. It is therefore to be expected that the compounds according to the invention will be suitable for the prevention or treatment of diseases or conditions such as type 1 and type 2 diabetes mellitus, diabetic complications (such as e.g. retinopathy, nephropathy or neuropathies), metabolic acidosis or ketosis, reactive hypoglycaemia, insulin resistance, metabolic syndrome, dyslipidaemias of various origins, arthritis, atherosclerosis and related diseases, obesity, allograft transplantation and calcitonin-induced osteoporosis. In addition these substances are capable of preventing B-cell degeneration such as e.g. apoptosis or necrosis of pancreatic B-cells. The substances are also suitable for improving or restoring the function of pancreatic cells and also increasing the number and size of pancreatic B-cells. Additionally, and on the basis of the role of the Glucagon-Like Peptides, such as e.g. GLP-1 and GLP-2 and their link with DPP-IV inhibition, it is likely that the compounds according to the invention are suitable for achieving, inter alia, a sedative or anxiety-relieving effect and also for favourably affecting catabolic states after operations or hormonal stress responses or reducing mortality or morbidity after myocardial infarct. They are also suitable for treating all conditions which are connected with the above mentioned effects and which are mediated by GLP-1 or GLP-2. The compounds according to the invention may also be used as diuretics or antihypertensives and are suitable for preventing and treating acute renal failure. Furthermore, the compounds according to the invention may be used to treat inflammatory diseases of the respiratory tract. They are also suitable for the prevention and treatment of chronic inflammatory intestinal diseases such as e.g. irritable bowel syndrome (IBS), Crohn's disease or ulcerative colitis and also pancreatitis. It is also likely that they can be used for all kinds of damage to or impairment of the gastrointestinal tract such as colitis and enteritis, for example. It is also expected that DPP-IV inhibitors and hence also the compounds according to the invention may be used to treat infertility or to improve fertility in humans or mammals, particularly when the infertility is connected with insulin resistance or polycystic ovary syndrome. On the other hand these substances are suitable for affecting sperm motility and can thus be used as male contraceptives. The substances are also suitable for treating deficiencies of growth hormone which are associated with reduced stature, and may also be used to advantage in any indications in which growth hormone may be used. The compounds according to the invention are also suitable, on the basis of their inhibitory effect on DPP-IV, for treating various autoimmune diseases such as e.g. rheumatoid arthritis, multiple sclerosis, thyroiditis and Basedow's disease, etc. They may also be used to treat viral diseases and also, for example, in HIV infections, for stimulating blood production, in benign prostatic—hyperplasia, gingivitis, as well as for the treatment of neuronal defects and neurodegenerative diseases such as Alzheimer's disease, for example. The compounds described may also be used for the treatment of tumours, particularly for modifying tumour invasion and also metastasisation; examples here are their use in treating T-cell lymphomas, acute lymphoblastic leukaemia, cell-based pancreatic carcinomas, basal cell carcinomas or breast cancers. Other indications are stroke, ischaemia of various origins, Parkinson's disease and migraine. In addition, further indications include follicular and epidermal hyperkeratoses, increased keratinocyte proliferation, psoriasis, encephalomyelitis, glomerulonephritis, lipodystrophies, as well as psychosomatic, depressive and neuropsychiatric diseases of all kinds.
The compounds according to the invention may also be used in conjunction with other active substances. Therapeutic agents which are suitable for such combinations include, for example, antidiabetics, such as metformin, sulphonylureas (e.g. glibenclamide, tolbutamide, glimepiride), nateglinide, repaglinide, thiazolidinedione (e.g. rosiglitazone, pioglitazone), PPAR-gamma agonists (e.g. GI 262570) and antagonists, PPAR-gamma/alpha modulators (e.g. KRP 297), alpha-glucosidase inhibitors (e.g. acarbose, voglibose), other DPPIV inhibitors, alpha2 antagonists, insulin and insulin analogues, GLP-1 and GLP-1 analogues (e.g. exendin-4) or amylin. Also, SGLT2 inhibitors such as T-1095, inhibitors of protein tyrosine phosphatase 1, substances which influence deregulated glucose production in the liver, such as e.g. inhibitors of glucose-6-phosphatase, or fructose-1,6-bisphosphatase, glycogen phosphorylase, glucagon receptor antagonists and inhibitors of phosphoenol—pyruvate carboxykinase, glycogen synthase kinase or pyruvate dehydrokinase, lipid lowering agents, such as HMG-CoA-reductase inhibitors (e.g. simvastatin, atorvastatin), fibrates (e.g. bezafibrate, fenofibrate), nicotinic acid and its derivatives, PPAR-alpha agonists, PPAR-delta agonists, ACAT inhibitors (e.g. avasimibe) or cholesterol resorption inhibitors such as for example ezetimibe, bile acid-binding substances such as for example cholestyramine, inhibitors of ileac bile acid transport, HDL-raising compounds such as for example inhibitors of CETP or regulators of ABC1 or active substances for the treatment of obesity, such as e.g. sibutramine or tetrahydrolipostatin, dexfenfluramine, axokine, antagonists of the cannabinoid1 receptor, MCH-1 receptor antagonists, MC4 receptor agonists, NPY5 or NPY2 antagonists or β3-agonists such as SB-418790 or AD-9677 as well as agonists of the 5HT2c receptor.
It is also possible to combine the compounds with drugs for treating high blood pressure such as e.g. AII antagonists or ACE inhibitors, diuretics, β-blockers, Ca-antagonists, etc., or combinations thereof.
The dosage required to achieve such an effect is expediently, by intravenous route, 1 to 100 mg, preferably 1 to 30 mg, and by oral route 1 to 1000 mg, preferably 1 to 100 mg, in each case 1 to 4 times a day. For this purpose, the compounds of formula I prepared according to the invention, optionally combined with other active substances, may be incorporated together with one or more inert conventional carriers and/or diluents, e.g. with corn starch, lactose, glucose, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water, water/ethanol, water/glycerol, water/sorbitol, water/polyethylene glycol, propylene glycol, cetylstearyl alcohol, carboxymethylcellulose or fatty substances such as hard fat or suitable mixtures thereof into conventional galenic preparations such as plain or coated tablets, capsules, powders, suspensions or suppositories.
The Examples that follow are intended to illustrate the invention:
Preparation of the starting compounds:
A mixture of 555 mg of 8-bromotheophyllin and 0.39 ml of Hünig base in 9 ml N,N-dimethylformamide is combined with 600 mg of 2-bromomethyl-isophthalonitrile and stirred overnight at ambient temperature. For working up the reaction mixture is poured onto water. The precipitate formed is suction filtered, washed with water and dried.
Yield: 686 mg (83% of theory)
Rf value: 0.56 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=399, 401 [M+H]+
The following compounds are obtained analogously to Example I:
Mass spectrum (ESI+): m/z=269, 271 [M+H]+
Mass spectrum (ESI+): m/z=316, 318 [M+H]+
Mass spectrum (ESI+): m/z=415, 417 [M+H]+
(Carried out in the presence of potassium carbonate)
Mass spectrum (ESI+): m/z=375, 377 [M+H]+
Mass spectrum (ESI+): m/z=313, 315 [M+H]+
Rf value: 0.43 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=327, 329 [M+H]+
Rf value: 0.72 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=297/299 [M+H]+
(The product is contaminated with approx. 10-20% of Z compound)
Rf value: 0.55 (silica gel, cyclohexane/ethyl acetate/methanol=6:3:1)
Mass spectrum (ESI+): m/z=299, 301 [M+H]+
Mass spectrum (ESI+): m/z=325, 327 [M+H]+
Mass spectrum (ESI+): m/z=443, 445 [M+H]+
(product contains approx. 25% of Z isomer)
Mass spectrum (ESI+): m/z=417, 419 [M+H]+
Rf value: 0.71 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=417, 419 [M+H]+
Rf value: 0.68 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=481, 483, 485 [M+H]+
Rf value: 0.60 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=443, 445 [M+H]+
Rf value: 0.77 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=437, 439, 441 [M+H]+
Rf value: 0.77 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=431, 433 [M+H]+
Rf value: 0.77 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=431, 433 [M+H]+
Rf value: 0.83 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=527, 529 [M+H]+
(The [(1-chloro-3-methyl-butyl)sulphanyl]-benzene used as starting material for the reaction is obtained by chlorination of [(3-methyl-butyl)sulphanyl]-benzene with N-chloro-succinimide in carbon tetrachloride)
Rf value: 0.38 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=423, 425 [M+H]+
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=1:1)
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=1:1)
Rf value: 0.45 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=223/225 [M+H]+
63 mg of ethyl bromoacetate are added to a mixture of 200 mg of 1-[2-(2-hydroxy-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine and 63 mg of potassium carbonate in 3 ml N,N-dimethylformamide. The reaction mixture is stirred for five hours at ambient temperature. For working up it is combined with water and the precipitate formed is suction filtered, washed with water and dried for three hours at 80° C. in the drying cupboard.
Yield: 216 mg (94% of theory)
Mass spectrum (ESI+): m/z=653 [M+H]+
The following compounds are obtained analogously to Example II:
Mass spectrum (ESI+): m/z=624 [M+H]+
Rf value: 0.20 (silica gel, cyclohexane/ethyl acetate=6:4)
Mass spectrum (ESI+): m/z=627 [M+H]+
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=638 [M+H]+
Mass spectrum (ESI+): m/z=652 [M+H]+
Mass spectrum (ESI+): m/z=639 [M+H]+
Mass spectrum (ESI+): m/z=636 [M+H]+
Mass spectrum (ESI+): m/z=650 [M+H]+
Mass spectrum (ESI+): m/z=622 [M+H]+
Mass spectrum (ESI+): m/z=608 [M+H]+
Mass spectrum (ESI+): m/z=623 [M+H]+
Mass spectrum (ESI+): m/z=667 [M+H]+
Mass spectrum (ESI+): m/z=622 [M+H]+
(product contains some Z isomer)
Rf value: 0.35 (silica gel, cyclohexane/ethyl acetate/methanol=5:4:1)
Mass spectrum (ESI+): m/z=624 [M+H]+
Mass spectrum (ESI+): m/z=636 [M+H]+
Mass spectrum (ESI+): m/z=622 [M+H]+
Mass spectrum (ESI+): m/z=639 [M+H]+
Mass spectrum (ESI+): m/z=638 [M+H]+
Mass spectrum (ESI+): m/z=222 [M+H]+
Mass spectrum (ESI+): m/z=637 [M+H]+
Mass spectrum (ESI+): m/z=622 [M+H]+
Mass spectrum (ESI+): m/z=208 [M+H]+
Mass spectrum (ESI+): m/z=607 [M+H]+
Mass spectrum (ESI+): m/z=665 [M+H]+
Mass spectrum (ESI+): m/z=590 [M+H]+
Mass spectrum (ESI+): m/z=611 [M+H]+
(Formed as main product when 1-[2-(2-hydroxy-phenyl)-2-oxo-ethyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine is reacted with 1-chloro-3,3-dimethyl-butan-2-one)
Mass spectrum (ESI+): m/z=631 [M+H]+
1.30 g of 3-tert.-butyloxycarbonylamino-piperidine are added to a mixture of 2.51 g of 1-[2-(2-hydroxy-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-chloro-xanthine and 880 mg of sodium carbonate in 8 ml of dimethylsulphoxide. The reaction mixture is stirred for 18 hours at 60° C. For working up it is combined with water and the precipitate formed is suction filtered. The solid crude product is dissolved in ethyl acetate, the solution is dried over magnesium sulphate and evaporated down. The flask residue is chromatographed through a silica gel column with cyclohexane/ethyl acetate (10:1 to 1:1) as eluant.
Yield: 2.56 g (91% of theory)
Mass spectrum (ESI+): m/z=567 [M+H]+
The following compounds are obtained analogously to Example III:
Mass spectrum (ESI+): m/z=433 [M+H]+
Mass spectrum (ESI+): m/z=565 [M+H]+
Rf value: 0.90 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=478 [M−H]−
Mass spectrum (ESI+): m/z=552 [M+H]+
Mass spectrum (ESI+): m/z=519 [M+H]+
Mass spectrum (ESI+): m/z=518 [M+H]+
Rf value: 0.25 (silica gel, cyclohexane/ethyl acetate/methanol=7:2:1)
Mass spectrum (ESI+): m/z=596 [M+H]+
Mass spectrum (ESI+): m/z=520 [M+H]+
Mass spectrum (ESI+): m/z=535 [M+H]+
Rf value: 0.52 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=596 [M+H]+
Mass spectrum (ESI+): m/z=556 [M+H]+
Mass spectrum (ESI+): m/z=596 [M+H]+
Rf value: 0.62 (silica gel, ethyl acetate)
(Carried out with potassium carbonate in the presence of Hünig base)
Rf value: 0.27 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=720 [M+H]+
Rf value: 0.31 (silica gel, ethyl acetate/petroleum ether=7:3)
Mass spectrum (ESI+): m/z=574 [M+H]+
Rf value: 0.45 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5)
Mass spectrum (ESI+): m/z=605 [M+H]+
(Carried out with potassium carbonate)
Rf value: 0.42 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=447 [M+H]+
(Carried out with potassium carbonate)
Melting point: 235-237° C.
Mass spectrum (ESI+): m/z=417 [M+H]+
(Carried out with potassium carbonate)
Rf value: 0.36 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=558 [M+H]+
(Carried out with potassium carbonate)
Rf value: 0.71 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=558 [M+H]+
(Carried out with potassium carbonate; the product contains approx. 20% of Z isomer)
Rf value: 0.24 (silica gel, ethyl acetate/petroleum ether=1:1)
Mass spectrum (ESI+): m/z=560 [M+H]+
(Carried out with potassium carbonate)
Rf value: 0.64 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=417 [M+H]+
(Carried out with potassium carbonate)
Rf value: 0.64 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=417 [M+H]+
(product contains approx. 15% of Z isomer)
Rf value: 0.35 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=419 [M+H]+
(product contains approx. 15% of Z isomer)
Rf value: 0.35 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=419 [M+H]+
Mass spectrum (ESI+): m/z=551 [M+H]+
Mass spectrum (ESI+): m/z=578 [M+H]+
Mass spectrum (ESI+): m/z=563 [M+H]+
Mass spectrum (ESI+): m/z=579 [M+H]+
Mass spectrum (ESI+): m/z=522 [M+H]+
Mass spectrum (ESI+): m/z=551 [M+H]+
(product contains approx. 10% of Z isomer)
Rf value: 0.20 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=552 [M+H]+
(product contains approx. 25% of Z isomer)
Mass spectrum (ESI+): m/z=537 [M+H]+
(product contains some Z isomer)
Rf value: 0.30 (silica gel, cyclohexane/ethyl acetate=4:6)
Mass spectrum (ESI+): m/z=553 [M+H]+
Mass spectrum (ESI+): m/z=551 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=550 [M+H]+
Mass spectrum (ESI+): m/z=567 [M+H]+
Mass spectrum (ESI+): m/z=535 [M+H]+
Mass spectrum (ESI+): m/z=610 [M+H]+
(Carried out with potassium carbonate)
Rf value: 0.52 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=417 [M+H]+
Rf value: 0.46 (silica gel, methylene chloride/methanol=95:5)
Rf value: 0.22 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=601, 603 [M+H]+
Rf value: 0.41 (silica gel, methylene chloride/methanol=95:5)
Rf value: 0.49 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=557, 559 [M+H]+
Mass spectrum (ESI+): m/z=535 [M+H]+
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate=4:6)
Mass spectrum (ESI+): m/z=552 [M+H]+
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=582 [M+H]+
Mass spectrum (ESI+): m/z=626 [M+H]+
Mass spectrum (ESI+): m/z=738 [M+H]+
Rf value: 0.48 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=551 [M+H]+
Mass spectrum (ESI+): m/z=551 [M+H]+
Rf value: 0.40 (silica gel, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=722 [M+H]+
Mass spectrum (ESI+): m/z=615 [M+H]+
Mass spectrum (ESI+): m/z=615 [M+H]+
Rf value: 0.80 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=560 [M+H]+
Rf value: 0.50 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=558 [M+H]+
Rf value: 0.40 (silica gel, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=646 [M+H]+
Rf value: 0.15 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=691 [M+H]+
Rf value: 0.35 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=586 [M+H]+
Rf value: 0.23 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=677 [M+H]+
Rf value: 0.46 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=547 [M+H]+
Rf value: 0.48 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=537 [M+H]+
Rf value: 0.38 (silica gel, petroleum ether/ethyl acetate=1:1)
Rf value: 0.40 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=588 [M+H]+
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate=1:1)
Rf value: 0.42 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=635 [M+H]+
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=443 [M+H]+
Rf value: 0.70 (silica gel, ethyl acetate)
Rf value: 0.35 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=443 [M+H]+
Mass spectrum (ESI+): m/z=644, 646 [M+H]+
Rf value: 0.39 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=644, 646 [M+H]+
Prepared by reacting (4-methyl-quinazolin-2-yl)-methylchloride and 3-methyl-7-(2-chlorobenzyl)-8-bromo-xanthine and subsequently reacting with (R)-3-(tert.-butyloxycarbonylamino)-piperidine
Mass spectrum (ESI+): m/z=645, 647 [M+H]+
Prepared by reacting (4-phenyl-quinazolin-2-yl)-methylchloride and 3-methyl-7-(2-chlorobenzyl)-8-bromo-xanthine and subsequently reacting with (R)-3-(tert.-butyloxycarbonylamino)-piperidine
Mass spectrum (ESI+): m/z=707, 709 [M+H]+
Prepared by treating 1-[2-(2-methoxy-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-chloro-xanthine with boron tribromide in methylene chloride. The desired product is contaminated with approx. 20% 1-[2-(2-hydroxy-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-bromo-3-methyl-butyl)-8-chloro-xanthine.
Mass spectrum (ESI+): m/z=403, 405 [M+H]+
The following compounds are obtained analogously to Example IV:
(product is contaminated with approx. 20% 1-[2-(2-hydroxy-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-bromo-2-buten-1-yl)-8-bromo-xanthine)
Mass spectrum (ESI+): m/z=431, 433 [M+H]+
Mass spectrum (ESI+): m/z=459, 461 [M+H]+
(product contains some Z isomer)
Rf value: 0.60 (silica gel, cyclohexane/ethyl acetate=4:6)
Mass spectrum (ESI+): m/z=433, 435 [M+H]+
Mass spectrum (ESI+): m/z=447, 449 [M+H]+
1.71 g of 2-bromo-1-(2-methoxy-phenyl)-ethanone are added to a mixture of 2.00 g of 3-methyl-7-(3-methyl-2-buten-1-yl)-8-chloro-xanthine and 1.38 mg of potassium carbonate in 15 ml of N,N-dimethylformamide. The reaction mixture is stirred for eight hours at ambient temperature. After aqueous working up the crude product is purified by chromatography through a silica gel column with cyclohexane/ethyl acetate (8:1 to 8:1) as eluant.
Yield: 2.61 g (84% of theory)
Mass spectrum (ESI+): m/z=417, 419 [M+H]+
The following compounds are obtained analogously to Example V:
(The reaction is carried out with 2-bromo-1-[3-(tert.-butyldimethylsilanyloxy)-phenyl]-ethanone)
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=567 [M+H]+
Mass spectrum (ESI+): m/z=401, 403 [M+H]+
Mass spectrum (ESI+): m/z=391, 393 [M+Na]+
Rf value: 0.90 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=600 [M+H]+
Mass spectrum (ESI+): m/z=667 [M+H]+
Rf value: 0.90 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=538 [M+H]+
Rf value: 0.60 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=412 [M+H]+
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate/methanol=7:2:1)
Mass spectrum (ESI+): m/z=432, 434 [M+H]+
Mass spectrum (ESI+): m/z=493, 495 [M+H]+
Rf value: 0.64 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=432, 434 [M+H]+
Mass spectrum (ESI+): m/z=476, 478 [M+H]+
Rf value: 0.45 (silica gel, ethyl acetate/petroleum ether=7:3)
Mass spectrum (ESI+): m/z=574 [M+H]+
(The starting material 4-bromomethyl-chromen-2-one is prepared analogously to Kimura et al., Chem. Pharm. Bull. 1982, 30, 552-558.)
Rf value: 0.52 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=591 [M+H]+
Rf value: 0.54 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=604 [M+H]+
Melting point: 195-197° C.
Mass spectrum (ESI+): m/z=575 [M+H]+
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=604 [M+H]+
Rf value: 0.18 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI+): m/z=591 [M+H]+
Rf value: 0.53 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=600 [M+H]+
Rf value: 0.73 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=600 [M+H]+
Rf value: 0.43 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=597 [M+H]+
(Carried out in N-methylpyrrolidin-2-one at 60° C.)
Rf value: 0.27 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=609 [M+H]+
(Carried out in N-methylpyrrolidin-2-one at 60° C.)
Rf value: 0.35 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=623 [M+H]+
(Carried out in N-methylpyrrolidin-2-one at 60° C.)
Rf value: 0.53 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=611 [M+H]+
(Carried out in N-methylpyrrolidin-2-one at 60° C.)
Rf value: 0.38 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=565 [M+H]+
Rf value: 0.54 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=549 [M+H]+
Rf value: 0.75 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=579 [M+H]+
Rf value: 0.61 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=662 [M+H]+
Rf value: 0.68 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=599 [M+H]+
Rf value: 0.83 (silica gel, ethyl acetate/petroleum ether=4:1)
Mass spectrum (ESI+): m/z=557 [M+H]+
Rf value: 0.25 (silica gel, ethyl acetate/petroleum ether=4:1)
Mass spectrum (ESI+): m/z=588 [M+H]+
Melting point: 163-165° C.
Mass spectrum (ESI+): m/z=557 [M+H]+
Rf value: 0.95 (silica gel, ethyl acetate/petroleum ether=4:1)
Mass spectrum (ESI+): m/z=531 [M+H]+
Rf value: 0.40 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=559 [M+H]+
Rf value: 0.80 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=571 [M+H]+
Rf value: 0.54 (silica gel, methylene chloride/methanol=95:5)
Rf value: 0.23 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=518 [M+H]+
Rf value: 0.44 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=558 [M+H]+
Rf value: 0.25 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=588 [M+H]+
Rf value: 0.30 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=604 [M+H]+
Rf value: 0.75 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=587 [M+H]+
Rf value: 0.80 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=587 [M+H]+
Rf value: 0.56 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=572 [M+H]+
Rf value: 0.83 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=611 [M+H]+
Rf value: 0.78 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=602 [M+H]+
Rf value: 0.39 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=544 [M+H]+
Rf value: 0.56 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=572 [M+H]+
Rf value: 0.78 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=557 [M+H]+
Rf value: 0.80 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=456 [M+H]+
Rf value: 0.40 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=558 [M+H]+
Rf value: 0.83 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=587 [M+H]+
Rf value: 0.38 (silica gel, ethyl acetate/petroleum ether=1:1)
Mass spectrum (ESI+): m/z=609 [M+H]+
(Carried out with potassium-tert. butoxide in dimethylsulphoxide)
Rf value: 0.48 (silica gel, ethyl acetate/petroleum ether=2:1)
Mass spectrum (ESI+): m/z=622 [M+H]+
Mass spectrum (ESI+): m/z=595 [M+H]+
Mass spectrum (ESI+): m/z=559 [M+H]+
Mass spectrum (ESI+): m/z=559 [M+H]+
(product contains approx. 15% of Z isomer)
Rf value: 0.30 (silica gel, ethyl acetate/cyclohexane=8:2)
Mass spectrum (ESI+): m/z=561 [M+H]+
(product contains approx. 15% of Z isomer)
Rf value: 0.30 (silica gel, ethyl acetate/cyclohexane=8:2)
Mass spectrum (ESI+): m/z=561 [M+H]+
(product contains approx. 17% of Z isomer)
Rf value: 0.58 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=574 [M+H]+
(product contains approx. 17% of Z isomer)
Rf value: 0.58 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=574 [M+H]+
Mass spectrum (ESI+): m/z=445, 447 [M+H]+
Mass spectrum (ESI+): m/z=488, 490 [M+H]+
Mass spectrum (ESI+): m/z=473, 475 [M+H]+
Rf value: 0.35 (silica gel, methylene chloride/methanol=95:5)
(product contains approx. 10% of Z isomer)
Rf value: 0.60 (silica gel, cyclohexane/ethyl acetate=4:6)
Mass spectrum (ESI+): m/z=462, 464 [M+H]+
(product contains some Z isomer)
Rf value: 0.30 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=447, 449 [M+H]+
Rf value: 0.77 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=460, 462 [M+H]+
(product contains approx. 20% of Z isomer)
Mass spectrum (ESI+): m/z=537 [M+H]+
Mass spectrum (ESI+): m/z=461, 463 [M+H]+
Rf value: 0.61 (silica gel, cyclohexane/ethyl acetate=4:6)
(product contains approx. 17% of Z isomer)
Mass spectrum (ESI+): m/z=638 [M+H]+
(product contains approx. 18% of Z isomer)
Rf value: 0.35 (silica gel, cyclohexane/ethyl acetate=6:4)
Mass spectrum (ESI+): m/z=537 [M+H]+
Rf value: 0.60 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=580 [M+H]+
Rf value: 0.52 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=572 [M+H]+
Mass spectrum (ESI+): m/z=572 [M+H]+
Mass spectrum (ESI+): m/z=572 [M+H]+
Mass spectrum (ESI+): m/z=572 [M+H]+
Rf value: 0.52 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=574 [M+H]+
Rf value: 0.52 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=574 [M+H]+
Rf value: 0.18 (silica gel, ethyl acetate/petroleum ether=1:1)
Mass spectrum (ESI+): m/z=593 [M+H]+
Mass spectrum (ESI+): m/z=593 [M+H]+
Rf value: 0.56 (silica gel, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=587 [M+H]+
Mass spectrum (ESI+): m/z=587 [M+H]+
Rf value: 0.86 (silica gel, ethyl acetate/petroleum ether=4:1)
Mass spectrum (ESI+): m/z=579 [M+H]+
Rf value: 0.86 (silica gel, ethyl acetate/petroleum ether=4:1)
Mass spectrum (ESI+): m/z=579 [M+H]+
Rf value: 0.48 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=573 [M+H]+
Rf value: 0.48 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=573 [M+H]+
Rf value: 0.50 (silica gel, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=622 [M+H]+
Mass spectrum (ESI+): m/z=638 [M+H]+
Mass spectrum (ESI+): m/z=624 [M+H]+
Mass spectrum (ESI+): m/z=624 [M+H]+
Rf value: 0.60 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=506, 508 [M+H]+
(Carried out in the presence of caesium carbonate)
Rf value: 0.40 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=602 [M+H]+
Rf value: 0.75 (silica gel, ethyl acetate/petroleum ether=1:1)
Mass spectrum (ESI+): m/z=618, 620 [M+H]+
Rf value: 0.44 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=547 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=559 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=619 [M+H]+
Rf value: 0.35 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=559 [M+H]+
Rf value: 0.30 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI−): m/z=600, 602 [M−H]−
Rf value: 0.44 (silica gel, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=573 [M+H]+
Rf value: 0.85 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=634 [M+H]+
Rf value: 0.60 (silica gel, ethyl acetate/methanol=3:1)
Mass spectrum (ESI+): m/z=586 [M+H]+
Mass spectrum (ESI+): m/z=547 [M+H]+
(Carried out in the presence of caesium carbonate)
Rf value: 0.28 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=644 [M+H]+
(Carried out in the presence of caesium carbonate)
Rf value: 0.35 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=642 [M+H]+
(Carried out in the presence of caesium carbonate)
Rf value: 0.50 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=743 [M+H]+
(Carried out in the presence of caesium carbonate)
Rf value: 0.59 (silica gel, ethyl acetate/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=628 [M+H]+
Rf value: 0.25 (silica gel, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=677 [M+H]+
Rf value: 0.77 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=582 [M+H]+
Mass spectrum (ESI+): m/z=547 [M+H]+
Rf value: 0.25 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=561 [M+H]+
Rf value: 0.60 (silica gel, ethyl acetate/methanol=9:1)
Mass spectrum (ESI+): m/z=588 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=588 [M+H]+
Mass spectrum (ESI+): m/z=635 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=561 [M+H]+
Mass spectrum (ESI+): m/z=563 [M+H]+
Rf value: 0.50 (silica gel, ethyl acetate/petroleum ether=1:1)
Mass spectrum (ESI+): m/z=851 [M+H]+
(By-product of the reaction of 3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxy-carbonylamino)-piperidin-1-yl]-xanthine with 1-chloromethyl-3-trifluoromethyl-3,4-dihydro-isoquinoline)
Rf value: 0.75 (aluminium oxide, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=608 [M+H]+
Mass spectrum (ESI+): m/z=495, 497 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=561 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=561 [M+H]+
Rf value: 0.10 (silica gel, ethyl acetate/methanol=98:2)
Mass spectrum (ESI+): m/z=561 [M+H]+
Rf value: 0.60 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=637 [M+H]+
Rf value: 0.50 (silica gel, ethyl acetate/petroleum ether=8:2)
Mass spectrum (ESI+): m/z=601 [M+H]+
Rf value: 0.53 (silica gel, ethyl acetate/petroleum ether=3:2)
Rf value: 0.50 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=623 [M+H]+
Rf value: 0.54 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=585 [M+H]+
Rf value: 0.50 (silica gel, ethyl acetate/methanol=24:1)
Mass spectrum (ESI+): m/z=588 [M+H]+
(By-product of the reaction of 3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxy-carbonylamino)-piperidin-1-yl]-xanthine with 1-chloromethyl-3-trifluoromethyl-3,4-dihydro-isoquinoline)
Rf value: 0.75 (aluminium oxide, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=608 [M+H]+
Rf value: 0.75 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=625 [M+H]+
Mass spectrum (ESI+): m/z=489 [M+H]+
Mass spectrum (ESI+): m/z=635 [M+H]+
(Carried out in the presence of caesium carbonate)
Rf value: 0.40 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=587 [M+H]+
Rf value: 0.55 (silica gel, ethyl acetate/petroleum ether=8:2)
Mass spectrum (ESI+): m/z=635 [M+H]+
Rf value: 0.55 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=466, 468 [M+H]+
Rf value: 0.65 (aluminium oxide, ethyl acetate/petroleum ether=3:1)
Mass spectrum (ESI+): m/z=576 [M+H]+
Rf value: 0.40 (aluminium oxide, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=590 [M+H]+
Rf value: 0.55 (silica gel, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=674 [M+H]+
Mass spectrum (EI): m/z=587 [M]+
Mass spectrum (ESI+): m/z=704 [M+H]+
Mass spectrum (ESI+): m/z=601 [M+H]+
Mass spectrum (ESI+): m/z=573 [M+H]+
Rf value: 0.65 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=573 [M+H]+
Rf value: 0.65 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=666, 668 [M+H]+
Rf value: 0.80 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=623 [M+H]+
Rf value: 0.83 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=578 [M+H]+
Mass spectrum (ESI+): m/z=623 [M+H]+
Rf value: 0.41 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=602 [M+H]+
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=548 [M+H]+
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate/methanol=5:4:1)
Mass spectrum (ESI+): m/z=593 [M+H]+
Rf value: 0.65 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=468, 470 [M+H]+
Mass spectrum (ESI+): m/z=558 [M+H]+
Mass spectrum (ESI+): m/z=559 [M+H]+
Rf value: 0.45 (silica gel, methylene chloride/methanol=19:1)
Mass spectrum (ESI+): m/z=573 [M+H]+
Rf value: 0.32 (silica gel, methylene chloride/methanol=96:4)
Mass spectrum (ESI+): m/z=601 [M+H]+
Rf value: 0.20 (silica gel, ethyl acetate/methanol=98:2)
Mass spectrum (ESI+): m/z=559 [M+H]+
Rf value: 0.12 (silica gel, ethyl acetate/methanol=98:2)
Mass spectrum (ESI+): m/z=559 [M+H]+
Rf value: 0.47 (silica gel, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=575 [M+H]+
Rf value: 0.39 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=559 [M+H]+
Rf value: 0.60 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=606 [M+H]+
Rf value: 0.48 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=356 [M+H]+
Rf value: 0.25 (silica gel, ethyl acetate/petroleum ether=4:1)
Mass spectrum (ESI+): m/z=559 [M+H]+
Mass spectrum (ESI+): m/z=623 [M+H]+
Mass spectrum (ESI+): m/z=601 [M+H]+
Mass spectrum (ESI+): m/z=601 [M+H]+
Mass spectrum (ESI+): m/z=601 [M+H]+
Rf value: 0.68 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=626 [M+H]+
Rf value: 0.38 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=608 [M+H]+
Rf value: 0.65 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=622, 624 [M+H]+
Rf value: 0.25 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=603 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=617 [M+H]+
Rf value: 0.56 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=578 [M+H]+
Rf value: 0.75 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=634 [M+H]+
Rf value: 0.35 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=651 [M+H]+
Rf value: 0.45 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=661 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=598 [M+H]+
Rf value: 0.77 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=601 [M+H]+
Rf value: 0.65 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=635 [M+H]+
Rf value: 0.57 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=565 [M+H]+
Rf value: 0.63 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=565 [M+H]+
Rf value: 0.64 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=619 [M+H]+
Rf value: 0.70 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=611 [M+H]+
Rf value: 0.75 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=611 [M+H]+
Rf value: 0.66 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=593 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=598 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=661 [M+H]+
Rf value: 0.75 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=608 [M+H]+
Rf value: 0.85 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=627 [M+H]+
Rf value: 0.72 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=579 [M+H]+
Rf value: 0.67 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=565 [M+H]+
Rf value: 0.57 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=565 [M+H]+
Rf value: 0.55 (silica gel, ethyl acetate/petroleum ether=2:1)
Mass spectrum (ESI+): m/z=612 [M+H]+
To a solution of 402 mg of 1-(2-{3-[(methylsulphanyl)methoxy]-phenyl}-2-oxo-ethyl)-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine in 10 ml hexafluoroisopropanol are added 0.15 ml of a 35% hydrogen peroxide solution. The reaction mixture is stirred for half an hour at ambient temperature. Then 5 ml of a 10% sodium thiosulphate solution are added. The aqueous phase is extracted twice with 5 ml of methylene chloride. The combined extracts are dried over sodium sulphate and evaporated down. The yellow residue is purified by chromatography through a silica gel column with cyclohexane/ethyl acetate/methanol (5:4:1) as eluant.
Yield: 299 mg (73% of theory)
Rf value: 0.28 (silica gel, cyclohexane/ethyl acetate/methanol=5:4:1)
Mass spectrum (ESI+): m/z=643 [M+H]+
The following compounds are obtained analogously to Example VI:
Rf value: 0.05 (silica gel, ethyl acetate/cyclohexane=3:1)
Mass spectrum (ESI+): m/z=613 [M+H]+
Mass spectrum (ESI+): m/z=627 [M+H]+
236 μl of 1,8-diazabicyclo[5.4.0]undec-7-ene are added dropwise to 630 mg of 7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine in 11 ml of acetonitrile. The solution is stirred for two hours at ambient temperature, then the acetonitrile is distilled off in vacuo. The flask residue is taken up in 11 ml of N,N-dimethylformamide and combined with 258 mg of (2-trimethylsilanyl-ethoxy)methyl chloride. The reaction mixture is stirred for three hours at 120° C. For working up water is added, the precipitate formed is filtered off and taken up in ethyl acetate. The solution is dried over magnesium sulphate, evaporated down and chromatographed through a silica gel column with cyclohexane/ethyl acetate/methanol (6:1:0 to 0:5:1) as eluant.
Yield: 435 mg (53% of theory)
Mass spectrum (ESI+): m/z=549 [M+H]+
The following compounds are obtained analogously to Example VII:
Mass spectrum (ESI−): m/z=396 [M−H]−
Rf value: 0.31 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=491 [M+H]+
510 mg of potassium-tert. butoxide are added to 2.32 g of 2-[3-(tert.-butyloxycarbonyl-amino)-piperidin-1-yl]-3-(3-methyl-2-buten-1-yl)-4-ethoxycarbonyl-5-{[(ethoxycarbonylamino)carbonyl]amino}-3H-imidazole in 35 ml of ethanol. The yellow solution is refluxed for five hours. After cooling to ambient temperature it is diluted with methylene chloride. The organic phase is washed with saturated ammonium chloride solution and saturated sodium chloride solution, dried over magnesium sulphate and evaporated down. The crude product is purified by chromatography through a silica gel column with methylene chloride/methanol/conc. methanolic ammonia (95:5:1 to 90:10:1) as eluant.
Yield: 630 mg (35% of theory)
Rf value: 0.24 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=419 [M+H]+
2.97 ml of ethyl isocyanatoformate are added to 4.00 g of 2-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-3-(3-methyl-2-buten-1-yl)-4-ethoxycarbonyl-5-amino-3H-imidazole in 90 ml of 1,2-dimethoxyethane and the light brown solution is heated overnight at 120° C. in an oil bath. Then a further 0.6 ml of ethyl isocyanatoformate is added and heating is continued for a further four hours. For working up the reaction mixture is combined with saturated potassium carbonate solution and extracted with ethyl acetate. The organic phase is dried over magnesium sulphate, evaporated down and purified through a silica gel column with methylene chloride/methanol/conc. methanolic ammonia (98:2:1 to 90:10:1) as eluant.
Yield: 2.27 g (45% of theory)
Rf value: 0.29 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=537 [M+H]+
Prepared by refluxing cyanimino-[N-(3-methyl-2-buten-1-yl)-N-(ethoxycarbonylmethyl)-amino]-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-methane with sodium in ethanol.
Rf value: 0.26 (aluminium oxide, ethyl acetate/petroleum ether=8:2)
Mass spectrum (ESI+): m/z=422 [M+H]+
Prepared by reacting cyanimino-[N-(3-methyl-2-buten-1-yl)-N-(ethoxycarbonylmethyl)-amino]-phenyloxy-methane with 3-(tert.-butyloxycarbonylamino)-piperidine in the presence of potassium carbonate in N,N-dimethylformamide at ambient temperature.
Rf value: 0.10 (silica gel, petroleum ether/ethyl acetate=6:4)
Mass spectrum (ESI+): m/z=422 [M+H]+
Prepared by reacting cyanimino-[(ethoxycarbonylmethyl)amino]-phenyloxy-methane with 1-bromo-3-methyl-2-butene in the presence of potassium carbonate in acetone at ambient temperature.
Rf value: 0.70 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=316 [M+H]+
Prepared by reacting diphenylcyanocarbonimidate with ethyl aminoacetate-hydrochloride in the presence of triethylamine in isopropanol at ambient temperature (analogously to R. Besse et al., Tetrahedron 1990, 46, 7803-7812).
Rf value: 0.73 (silica gel, petroleum ether/ethyl acetate=8:2)
Mass spectrum (ESI+): m/z=248 [M+H]+
Prepared by reacting 1-methyl-7-(2-cyano-benzyl)-8-chloro-xanthine with methyl bromoacetate in the presence of potassium carbonate in N,N-dimethylformamide at ambient temperature.
Rf value: 0.80 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=388, 390 [M+H]+
The following compounds are obtained analogously to Example XIV:
Mass spectrum (ESI+): m/z=355, 357 [M+H]+
Rf value: 0.80 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=354, 356 [M+H]+
Rf value: 0.90 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=356, 358 [M+H]+
Rf value: 0.78 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=576 [M+H]+
Mass spectrum (ESI+): m/z=358, 360 [M+H]+
Prepared by treating 1-methyl-3-[(2-trimethylsilanyl-ethoxy)methyl]-7-(2-cyano-benzyl)-8-chloro-xanthine with trifluoroacetic acid in methylene chloride at ambient temperature.
Rf value: 0.50 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=316, 318 [M+H]+
The following compounds are obtained analogously to Example XV:
Rf value: 0.26 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI−): m/z=361, 363 [M−H]−
(As the compound still contains impurities which cannot be removed by chromatography, the material is again converted into the BOC-protected derivative and then purified by chromatography, cf. Ex. XXV(1).)
Mass spectrum (ESI+): m/z=491 [M+H]+
Prepared by chlorination of 1-methyl-3-[(2-trimethylsilanyl-ethoxy)methyl]-7-(2-cyano-benzyl)-xanthine with N-chlorosuccinimide in dichloroethane while refluxing.
Mass spectrum (EI): m/z=445, 447 [M]+
Prepared by treating 16.68 g of 2-amino-7-(2-cyano-benzyl)-1,7-dihydro-purin-6-one with 17.00 g of sodium nitrite in a mixture of 375 ml of conc. acetic acid, 84 ml of water and 5.2 ml of conc. hydrochloric acid at 50° C.
Yield: 8.46 g (50% of theory)
Mass spectrum (ESI+): m/z=268 [M+H]+
Prepared by reacting 20.00 g of guanosine-hydrate with 22.54 g of 2-cyano-benzylbromide in dimethylsulphoxide at 60° C. and subsequent treatment with 57 ml of conc. hydrochloric acid.
Yield: 18.00 g (97% of theory)
Mass spectrum (ESI+): m/z=267 [M+H]+
Prepared by treating 1-[2-(3-{[(2-chloro-ethylamino)carbonyl]amino}-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with potassium-tert. butoxide in N,N-dimethylformamide at ambient temperature.
Rf value: 0.50 (silica gel, methylene chloride/methanol=9:1)
Prepared by reacting 221 mg of 1-[2-(3-amino-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with 60 μl of 2-chloroethyl isocyanate in 3 ml methylene chloride at ambient temperature.
Yield: 163 mg (64% of theory)
Rf value: 0.20 (silica gel, cyclohexane/ethyl acetate/methanol=6:3:1)
Mass spectrum (ESI+): m/z=671, 673 [M+H]+
The following compounds are obtained analogously to Example XX:
(Carried out in N,N-dimethylformamide at 30° C.)
Rf value: 0.26 (silica gel, cyclohexane/ethyl acetate=4:6)
Mass spectrum (ESI+): m/z=681 [M+H]+
Prepared by treating 1-[2-(3-nitro-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with iron powder in a mixture of ethanol, water and glacial acetic acid (80:25:10) at 100° C.
Rf value: 0.55 (silica gel, cyclohexane/ethyl acetate/methanol/conc. aqueous ammonia=50:30:20:1)
Mass spectrum (ESI+): m/z=566 [M+H]+
The following compounds are obtained analogously to Example XXI:
Mass spectrum (ESI+): m/z=566 [M+H]+
Mass spectrum (ESI+): m/z=566 [M+H]+
Rf value: 0.22 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=589 [M+H]+
Mass spectrum (ESI+): m/z=458, 460 [M+H]+
(product contains approx. 10% of Z isomer)
Rf value: 0.55 (silica gel, cyclohexane/ethyl acetate=4:6)
Mass spectrum (ESI+): m/z=432, 434 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=430, 432 [M+H]+
Mass spectrum (ESI+): m/z=552 [M+H]+
Mass spectrum (ESI+): m/z=552 [M+H]+
Rf value: 0.82 (silica gel, ethyl acetate/petroleum ether=4:1)
Mass spectrum (ESI+): m/z=596 [M+H]+
Prepared by reacting 248 mg of 1-[2-(2-amino-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with 40 μl of propionic acid chloride in the presence of 60 μl of pyridine in N,N-dimethylformamide at 80° C.
Yield: 168 mg (62% of theory)
Rf value: 0.55 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=622 [M+H]+
The following compounds are obtained analogously to Example XXII:
(Carried out with methyl bromoacetate and potassium carbonate)
Rf value: 0.42 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=661 [M+H]+
(product contains approx. 10% of Z isomer)
Mass spectrum (ESI+): m/z=594 [M+H]+
(product contains approx. 10% of Z isomer)
Mass spectrum (ESI+): m/z=622 [M+H]+
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=608 [M+H]+
Rf value: 0.34 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=592 [M+H]+
Rf value: 0.25 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=636 [M+H]+
Rf value: 0.44 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=620 [M+H]+
Rf value: 0.34 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=592 [M+H]+
Rf value: 0.44 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=620 [M+H]+
(Carried out in acetonitrile at 55° C.)
Rf value: 0.25 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=624 [M+H]+
(Carried out in acetonitrile at 65° C.)
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate/isopropanol=14:3:3)
Mass spectrum (ESI+): m/z=622 [M+H]+
Mass spectrum (ESI+): m/z=608 [M+H]+
Mass spectrum (ESI+): m/z=594 [M+H]+
Rf value: 0.28 (silica gel, cyclohexane/ethyl acetate/isopropanol=8:1:1)
Mass spectrum (ESI+): m/z=594 [M+H]+
Rf value: 0.90 (silica gel, methylene chloride/methanol=9:1)
(Carried out in 1,2-dichloroethane at 45° C.)
Rf value: 0.30 (silica gel, cyclohexane/ethyl acetate/isopropanol=8:1:1)
Mass spectrum (ESI+): m/z=622 [M+H]+
Rf value: 0.48 (silica gel, cyclohexane/ethyl acetate/isopropanol=14:3:3)
Mass spectrum (ESI+): m/z=608 [M+H]+
Mass spectrum (ESI+): m/z=606 [M+H]+
Rf value: 0.22 (silica gel, methylene chloride/methanol=95:5)
Rf value: 0.55 (silica gel, cyclohexane/ethyl acetate/isopropanol=14:3:3)
Mass spectrum (ESI+): m/z=656 [M+H]+
(Carried out with Hünig base and 4-dimethylamino-pyridine in methylene chloride)
Rf value: 0.60 (silica gel, methylene chloride/methanol=18:1)
Prepared by treating 1-(2-{3-[(methoxycarbonyl)methoxy]-phenyl}-2-oxo-ethyl)-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with trifluoroacetic acid in methylene chloride at ambient temperature.
Mass spectrum (ESI+): m/z=539 [M+H]+
The following compounds are obtained analogously to Example XXIII:
Mass spectrum (ESI+): m/z=539 [M+H]+
A mixture of 829 mg of 1-methyl-7-(2-cyano-benzyl)-8-chloro-xanthine, 640 mg of phenylboric acid, 509 mg of anhydrous copper acetate and 0.43 ml of pyridine in 20 ml methylene chloride is stirred for four days at ambient temperature in the presence of 100 mg of 4 Å molecular sieves. Then another 320 mg of phenylboric acid are added and the reaction mixture is stirred for another day at ambient temperature. For working up the mixture is filtered through talc and washed with ethyl acetate. The filtrate is evaporated down and chromatographed through a silica gel column with cyclohexane/ethyl acetate (7:3 to 1:1) as eluant.
Yield: 142 mg (14% of theory)
Mass spectrum (ESI+): m/z=392, 394 [M+H]+
Prepared by reacting 1-(2-phenyl-2-oxo-ethyl)-7-(3-methyl-2-buten-1-yl)-8-(3-amino-piperidin-1-yl)-xanthine with di-tert.butyl pyrocarbonate in the presence of Hünig base in methylene chloride at ambient temperature.
Rf value: 0.27 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
The following compounds are obtained analogously to Example XXV:
Rf value: 0.27 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=591 [M+H]+
Rf value: 0.82 (silica gel, methylene chloride/petroleum ether/ethyl acetate=5:4:1)
Mass spectrum (ESI+): m/z=260 [M+H]+
510 mg of a mixture of (cinnolin-4-yl)-methanol and (1,4-dihydro-cinnolin-4-yl)-methanol (see Ex. XXVII) are added to 830 mg of 3-methyl-7-(3-methyl-2-buten-1-yl)-8-chloro-xanthine and 1.25 g of triphenylphosphine in 25 ml of tetrahydrofuran. The reaction mixture is combined with 0.92 ml diethyl azodicarboxylate and stirred overnight at ambient temperature. Then it is evaporated down and chromatographed through a silica gel column with ethyl acetate/petroleum ether (7:3 to 0:1) as eluant. A mixture of cinnoline and 1,4-dihydro-cinnoline compound is obtained.
Yield: 660 mg (52% of theory)
Rf value: 0.60 (silica gel, ethyl acetate/petroleum ether=7:3)
The following compounds are obtained analogously to Example XXVI:
Rf value: 0.85 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=557, 559 [M+H]+
Melting point: 194-195° C.
Mass spectrum (ESI+): m/z=410, 412 [M+H]+
Rf value: 0.66 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=441, 443 [M+H]+
(Carried out with potassium carbonate)
Rf value: 0.45 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=438, 440 [M+H]+
Rf value: 0.78 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=438, 440 [M+H]+
Rf value: 0.80 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=600 [M+H]+
(The product contains approx. 20% of Z isomer)
Rf value: 0.71 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=440, 442 [M+H]+
Rf value: 0.95 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=440, 442 [M+H]+
Rf value: 0.55 (silica gel, ethyl acetate/petroleum ether=8:2)
Mass spectrum (ESI+): m/z=438, 440 [M+H]+
Rf value: 0.74 (silica gel, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=526, 528 [M+H]+
Mass spectrum (ESI+): m/z=571, 573 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=557, 559 [M+H]+
Rf value: 0.35 (silica gel, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=427, 429 [M+H]+
A solution of 1.00 g of methyl cinnolin-4-carboxylate in 15 ml diethyl ether is added dropwise at 0° C. to a suspension of 222 mg of lithium aluminium hydride in 5 ml of diethyl ether. After 1.5 hours water is carefully added dropwise to the reaction mixture, this is stirred with methylene chloride and suction filtered through a glass fibre filter. The aqueous phase is extracted with methylene chloride and the combined organic phases are dried over magnesium sulphate and evaporated down. According to 1H-NMR a mixture of cinnoline and 1,4-dihydro-cinnoline compound is obtained as a yellow oil which is reacted further without any more purification.
Yield: 530 mg (62% of theory)
Rf value: 0.63 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=161 [M1+H]+ and 163 [M2+H]+
The following compounds are obtained analogously to Example XXVII:
(mixed with {2-methyl-3-[(2-trimethylsilanyl-ethoxy)methyl]-3H-benzoimidazol-5-yl}-methanol)
Mass spectrum (ESI+): m/z=293 [M+H]+
Rf value: 0.45 (silica gel, petroleum ether/ethyl acetate=1:2)
Mass spectrum (ESI+): m/z=203 [M+H]+
Rf value: 0.18 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=175 [M+H]+
(Carried out with diisobutylaluminium hydride in toluene)
Mass spectrum (EI): m/z=224 [M]+
(Carried out with diisobutylaluminium hydride in toluene)
(Carried out with diisobutylaluminium hydride in toluene)
Mass spectrum (EI): m/z=202 [M]+
(Carried out with diisobutylaluminium hydride in toluene)
Prepared by treating methyl 4-oxo-3-[(2-trimethylsilanyl-ethoxy)methyl]-3,4-dihydro-phthalazin-1-carboxylate with sodium borohydride in tetrahydrofuran at 40° C.
Rf value: 0.55 (silica gel, cyclohexane/ethyl acetate 1:1)
Mass spectrum (ESI+): m/z=307 [M+H]+
The following compounds are obtained analogously to Example XXVIII:
(Carried out with lithium borohydride in tetrahydrofuran)
Rf value: 0.35 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI+): m/z=188 [M+H]+
(Carried out with lithium borohydride in tetrahydrofuran)
Rf value: 0.48 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=163 [M+H]+
(Carried out with lithium borohydride in tetrahydrofuran)
Rf value: 0.40 (aluminium oxide, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=178 [M+H]+
(Carried out with lithium borohydride in tetrahydrofuran)
Rf value: 0.45 (aluminium oxide, petroleum ether/ethyl acetate=3:1)
Mass spectrum (ESI+): m/z=192 [M+H]+
(Carried out with lithium borohydride in tetrahydrofuran at ambient temperature)
Rf value: 0.40 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI+): m/z=214 [M+H]+
Prepared by reacting methyl 4-oxo-3,4-dihydro-phthalazin-1-carboxylate with (2-trimethylsilanyl-ethoxy)methylchloride in the presence of Hünig base in methylene chloride at ambient temperature.
Rf value: 0.75 (silica gel, cyclohexane/ethyl acetate 6:4)
Mass spectrum (ESI+): m/z=335 [M+H]+
The following compounds are obtained analogously to Example XXIX:
Mass spectrum (ESI+): m/z=308 [M+H]+
Rf value: 0.87 (silica gel, methylene chloride/methanol=99:1)
(Carried out with potassium-tert. butoxide in N,N-dimethylformamide)
Rf value: 0.90 (silica gel, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=437 [M+H]+
Rf value: 0.78 (silica gel, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=290 [M+H]+
Mass spectrum (ESI+): m/z=321 [M+H]+
0.22 ml of a 35% hydrogen peroxide solution and 20 mg of sodium tungstate are added to 500 mg of 1-[2-(3-methylsulphanyl-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine in 5 ml methylene chloride. The reaction mixture is stirred overnight at ambient temperature, then 1 ml of methanol is added. After another 48 hours a further 1.5 ml of 35% hydrogen peroxide solution, a spatula tip of sodium tungstate and two drops of water are added. The next morning, the oxidation is complete according to thin layer chromatography and the reaction mixture is diluted with 50 ml methylene chloride and washed twice with 30 ml of 10% sodium thiosulphate solution. The organic phase is dried over magnesium sulphate and evaporated down, leaving a viscous resin which is reacted further without any more purification.
Yield: 530 mg (100% of theory)
Rf value: 0.72 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=629 [M+H]+
Prepared by treating 1-[2-(3-methoxycarbonyl-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with 3 M sodium hydroxide solution in methanol at ambient temperature.
Rf value: 0.34 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=595 [M+H]+
The following compounds are obtained analogously to Example XXXI:
Rf value: 0.49 (silica gel, methylene chloride/methanol=9:1)
(Carried out with 4 M potassium hydroxide solution in tetrahydrofuran)
Mass spectrum (ESI+): m/z=609 [M+H]+
(Carried out with 4 M potassium hydroxide solution in tetrahydrofuran)
Rf value: 0.65 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=610 [M+H]+
Mass spectrum (ESI+): m/z=475 [M+H]+
A mixture of 190 mg of 1-[2-(3-carboxy-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine, 43 μl of a 40% aqueous methylamine solution, 103 mg of O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate, 43 mg of N-hydroxybenzotriazole and 45 μl of triethylamine in 3 ml of tetrahydrofuran is stirred for eight hours at ambient temperature. For working up the reaction mixture is diluted with ethyl acetate and washed with water, 10% citric acid solution, 10% potassium carbonate solution and saturated sodium chloride solution. The organic phase is evaporated down and chromatographed through a silica gel column with methylene chloride/methanol (98:2 to 80:20) as eluant.
Yield: 173 mg (89% of theory)
Rf value: 0.30 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=608 [M+H]+
The following compounds are obtained analogously to Example XXXII:
Rf value: 0.28 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=622 [M+H]+
Rf value: 0.30 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=664 [M+H]+
Rf value: 0.30 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=622 [M+H]+
Rf value: 0.30 (silica gel, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=664 [M+H]+
(Carried out with Hünig base in N,N-dimethylformamide)
Mass spectrum (ESI+): m/z=650 [M+H]+
(Carried out with Hünig base in N,N-dimethylformamide)
Mass spectrum (ESI+): m/z=636 [M+H]+
(Carried out with Hünig base in N,N-dimethylformamide)
Mass spectrum (ESI+): m/z=662 [M+H]+
(Carried out with Hünig base in N,N-dimethylformamide)
Mass spectrum (ESI+): m/z=678 [M+H]+
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate/methanol=5:4:1)
Mass spectrum (ESI+): m/z=623 [M+H]+
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate/methanol=5:4:1)
Mass spectrum (ESI+): m/z=565 [M+H]+
Prepared by treating (4-methyl-isoquinolin-1-yl)-methanol with thionyl chloride in methylene chloride.
Rf value: 0.76 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=192, 194 [M+H]+
The following compounds are obtained analogously to Example XXXIII:
Rf value: 0.65 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI+): m/z=206, 208 [M+H]+
Mass spectrum (ESI+): m/z=208, 210 [M+H]+
Mass spectrum (EI): m/z=207, 209 [M]+
Rf value: 0.55 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=181, 183 [M+H]+
Mass spectrum (ESI+): m/z=208, 210 [M+H]+
Rf value: 0.50 (aluminium oxide, petroleum ether/ethyl acetate=10:1)
Mass spectrum (ESI+): m/z=196, 198 [M+H]+
Rf value: 0.50 (aluminium oxide, petroleum ether/ethyl acetate=10:1)
Mass spectrum (ESI+): m/z=210, 212 [M+H]+
Mass spectrum (ESI+): m/z=221, 223 [M+H]+
Mass spectrum (ESI+): m/z=193, 195 [M+H]+
Rf value: 0.50 (silica gel, petroleum ether/ethyl acetate=5:1)
Mass spectrum (ESI+): m/z=232, 234 [M+H]+
0.5 ml of a 1 M sodium methoxide solution in methanol is added dropwise to a solution of 428 mg of 1-cyanomethyl-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine in 3 ml of methanol at ambient temperature. After about 20 minutes the thick suspension formed is heated gently in a water bath and diluted with 2 ml of methanol. As soon as the reaction to form the iminoester is complete according to thin layer chromatography, the reaction mixture is neutralised with 0.5 ml 1 M glacial acetic acid solution in methanol and combined with a solution of 130 mg of anthranilic acid in 2 ml of methanol. Gentle heating produces a clear solution, which is stirred for 2.5 hours at ambient temperature. Then the reaction mixture is gently refluxed for about 3.5 hours. After standing overnight at ambient temperature the methanol is distilled off and the residue is stirred with cold water, suction filtered and dried. The crude product is suspended in 5 ml of methanol, gently heated and after cooling suction filtered, washed with methanol and dried in the desiccator.
Yield: 302 mg (56% of theory)
Rf value: 0.55 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=575 [M+H]+
The following compounds are obtained analogously to Example XXXV:
Rf value: 0.33 (silica gel, cyclohexane/ethyl acetate=6:4)
Mass spectrum (ESI−): m/z=223 [M−H]−
prepared by reduction of 4-dimethylamino-naphthalene-1-carbaldehyde with sodium borohydride in aqueous tetrahydrofuran.
Rf value: 0.67 (silica gel, cyclohexane/ethyl acetate=1:1)
prepared by bromination of 1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-ethanone in methylene chloride while cooling gently with an ice bath. The dibromo compound formed as a by-product is separated off by column chromatography.
Mass spectrum (ESI+): m/z=257, 259 [M+H]+
Rf value: 0.92 (silica gel, methylene chloride)
The following compounds are obtained analogously to Example XXXVI:
(bromination is carried out in dioxane at 40° C.; the product is contaminated with approx. 20% dibromo compound)
Rf value: 0.44 (silica gel, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=270, 272 [M+H]+
Mass spectrum (ESI+): m/z=243, 245 [M+H]+
Rf value: 0.94 (silica gel, methylene chloride)
(bromination is carried out with copper(II) bromide in dioxane)
Mass spectrum (ESI+): m/z=300, 302 [M+H]+
Rf value: 0.67 (silica gel, methylene chloride/methanol=99:1)
Mass spectrum (ESI+): m/z=270, 272 [M+H]+
Mass spectrum (ESI+): m/z=386, 388 [M+H]+
Rf value: 0.84 (silica gel, methylene chloride/methanol=99:1)
Mass spectrum (ESI+): m/z=384, 386 [M+H]+
Rf value: 0.38 (silica gel, ethyl acetate/petroleum ether=1:1)
Mass spectrum (ESI+): m/z=283, 285 [M+H]+
Rf value: 0.82 (silica gel, methylene chloride/methanol=99:1)
Rf value: 0.39 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI+): m/z=341, 343 [M+H]+
Mass spectrum (ESI−): m/z=277, 279 [M−H]−
Prepared by reacting 1-(2,3-dihydroxy-phenyl)-ethanone with 1,2-dibromoethane in the presence of potassium carbonate in N,N-dimethylformamide at 100° C.
Rf value: 0.43 (silica gel, ethyl acetate/petroleum ether=1:4)
Mass spectrum (ESI+): m/z=179 [M+H]+
Prepared by reacting 1-[(4-oxo-3,4-dihydro-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with methyl iodide in the presence of potassium carbonate in N,N-dimethylformamide at ambient temperature.
Rf value: 0.50 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=589 [M+H]+
The following compounds are obtained analogously to Example XXXVIII:
(The methylation is carried out in the presence of sodium carbonate in methanol)
Rf value: 0.46 (silica gel, petroleum ether/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=192 [M+H]+
(The methylation is carried out in the presence of sodium carbonate in methanol while refluxing)
Rf value: 0.67 (silica gel, methylene chloride/methanol=99:1)
Mass spectrum (ESI+): m/z=192 [M+H]+
(Carried out in the presence of potassium-tert. butoxide)
Rf value: 0.40 (silica gel, ethyl acetate/petroleum ether=2:1)
Mass spectrum (ESI+): m/z=205 [M+H]+
Rf value: 0.23 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI+): m/z=263 [M+H]+
Mass spectrum (ESI+): m/z=561 [M+H]+
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate/methanol=5:4:1)
Mass spectrum (ESI+): m/z=600 [M+H]+
Rf value: 0.45 (silica gel, cyclohexane/ethyl acetate/methanol=5:4:1)
Mass spectrum (ESI+): m/z=618 [M+H]+
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate/methanol=5:4:1)
Mass spectrum (ESI+): m/z=637 [M+H]+
Prepared by reacting 1-[2-(2-amino-phenyl)-2-oxo-ethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with paraformaldehyde and potassium cyanide in the presence of zinc chloride in glacial acetic acid at 40° C.
Rf value: 0.45 (silica gel, cyclohexane/ethyl acetate=3:7)
Mass spectrum (ESI+): m/z=605 [M+H]+
prepared by reduction of 1-[2-(2-nitro-phenyl)-2-oxo-ethyl]-3-methyl-7-(2-butyn-1-yl)-8-[(S)-3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with sodium dithionite in a mixture of methylglycol and water (2:1) at 100° C.
Rf value: 0.34 (silica gel, methylene chloride/methanol=95:5)
The following compounds are obtained analogously to Example XL:
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=4:6)
prepared by treatment of 2.95 g of 2-chloromethyl-4-methyl-quinazoline-3-oxide with 6 ml phosphorus trichloride in 150 ml chloroform while refluxing.
Yield: 1.75 g (57% of theory)
Rf value: 0.81 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=193, 195 [M+H]+
A freshly prepared solution of 202 mg of dimethylamine in 3.2 ml of tetrahydrofuran is added dropwise to 500 mg of 4-chloro-2-chloromethyl-quinazoline in 5 ml of tetrahydrofuran while cooling with an ice bath. Then the reaction mixture is stirred for another 3.5 hours while cooling with an ice bath and then for a further 30 minutes at ambient temperature.
The solvent is then gently distilled off using a rotary evaporator and the residue is taken up in methylene chloride. The solution is washed with saturated sodium hydrogen carbonate solution and with water, dried over magnesium sulphate and evaporated down. The solid residue is stirred with a little tert.-butylmethylether, suction filtered, washed with petroleum ether and dried in vacuo.
Yield: 323 mg (62% of theory)
Rf value: 0.60 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=222, 224 [M+H]+
The following compounds are obtained analogously to Example XLII:
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=264, 266 [M+H]+
Rf value: 0.70 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=262, 264 [M+H]+
Rf value: 0.57 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=363, 365 [M+H]+
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=248, 250 [M+H]+
(The reaction is carried out with sodium ethoxide in ethanol at ambient temperature.)
Rf value: 0.50 (silica gel, cyclohexane/ethyl acetate=3:1)
Mass spectrum (ESI+): m/z=223, 225 [M+H]+
(The reaction is carried out with sodium isopropoxide in isopropanol at ambient temperature.)
Rf value: 0.70 (silica gel, cyclohexane/ethyl acetate=3:1)
Mass spectrum (ESI+): m/z=237, 239 [M+H]+
(The reaction is carried out with sodium hydride and phenol in tetrahydrofuran at ambient temperature.)
Rf value: 0.65 (silica gel, cyclohexane/ethyl acetate=3:1)
Mass spectrum (ESI+): m/z=271, 273 [M+H]+
A solution of 110 μL of ethyl diazoacetate in 0.5 ml of toluene is added dropwise to 531 mg of 1-[2-(2-amino-phenyl)-2-oxo-ethyl]-3-methyl-7-((E)-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine and 10 mg of methyltrioxorhenium in 4.5 ml of toluene at ambient temperature under an argon atmosphere. The reaction mixture is stirred for 15 hours at ambient temperature. Then approx. another 5 mg of methyl-trioxorhenium and 20 μL ethyl diazoacetate are added and the reaction mixture is heated to 50° C. for two hours. After cooling to ambient temperature another 5 mg of methyltrioxorhenium and 20 μL ethyl diazoacetate are added. After another 16 hours at ambient temperature the reaction mixture is combined with 5 ml of conc. aqueous ammonia, shaken thoroughly and added to an Extrelut pack. After 15 min it is rinsed with 200 ml methylene chloride. The methylene chloride solution is evaporated down and chromatographed through a silica gel column with cyclohexane/ethyl acetate/isopropanol (8:2:0 to 8:1:1) as eluant.
Yield: 220 mg (36% of theory)
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=638 [M+H]+
A mixture of 215 mg of 1-{2-[2-cyanomethoxy-phenyl]-2-oxo-ethyl}-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine and 244 mg of caesium carbonate in 4 ml of N,N-dimethylformamide is stirred for two hours at 50° C., then a further three hours at 70° C. For working up the reaction mixture is combined with water and the precipitate formed is suction filtered and dried.
Yield: 130 mg (62% of theory)
Mass spectrum (ESI+): m/z=572 [M+H]+
Prepared by treating 1-[2-(1-ethoxycarbonyl-3-methyl-2-oxo-2,3-dihydro-1H-benzoimidazol-4-yl)-2-oxo-ethyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine with 1 N sodium hydroxide solution in methanol at ambient temperature.
Rf value: 0.36 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=605 [M+H]+
5.29 g of diethyldicarbonat and 611 mg of dimethylaminopyridine are added to 1.50 g of 1-(2,3-diamino-phenyl)-ethanone in 75 ml methylene chloride. The reaction mixture is stirred for three hours at ambient temperature, then another 100 mg of dimethylaminopyridine and 1 ml of diethyldicarbonate are added and the mixture is stirred for a further 20 hours at ambient temperature. For working up the reaction mixture is diluted with methylene chloride, washed with 2 N citric acid solution as well as saturated sodium hydrogen carbonate solution and saturated sodium chloride solution, dried over magnesium sulphate and evaporated down. The residue is chromatographed through a silica gel column with petroleum ether/ethyl acetate (3:1 to 1:2) as eluant. The desired product is stirred with a little tert.-butylmethylether, suction filtered, nachwashed with a little ethyl acetate and tert.-butylmethylether and dried.
Yield: 900 mg (36% of theory)
Rf value: 0.15 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI+): m/z=249 [M+H]+
501 mg of 1-cyanomethyl-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine are added to a mixture of 17 mg of potassium-tert. butoxide in 10 ml of methanol. After brief heating with stirring a clear solution is formed and after about 20 minutes the nitrile has largely reacted to form the iminoester according to thin layer chromatography. 206 mg of 2-amino-benzamidine-hydrochloride are then added and the reaction mixture is refluxed for four hours. After cooling to ambient temperature the precipitate formed is suction filtered, washed with methanol and dried.
Yield: 143 mg (23% of theory)
Rf value: 0.15 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=574 [M+H]+
150 mg of 1-(2-phenyl-2-oxo-ethyl)-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxy-carbonylamino)-piperidin-1-yl]-xanthine are hydrogenated in a mixture of 5 ml of tetrahydrofuran and 5 ml of methanol in the presence of 30 mg of 5% m palladium on activated charcoal (contaminated with quinoline) at ambient temperature, until the calculated amount of hydrogen has been taken up. Then a spatula tip of activated charcoal is added and the mixture is suction filtered. The filtrate is evaporated down and the crude product is purified by chromatography over a silica gel column with cyclohexane/ethyl acetate (7:3 to 4:6).
Yield: 120 mg (85% of theory)
Rf value: 0.40 (silica gel, cyclohexane/ethyl acetate=4:6)
Mass spectrum (ESI+): m/z=537 [M+H]+
148 mg of sodium hydride (approx. 60% in mineral oil) are added batchwise to a solution of 640 mg of 8-hydroxymethyl-quinolin-5-ol in N,N-dimethylformamide while cooling with an ice bath and the reaction mixture is slowly heated to ambient temperature. After the development of gas has ended, 230 μl methyl iodide are added dropwise while cooling with an ice bath, then the reaction mixture is stirred for approx. another two hours at ambient temperature. For working up it is poured onto ice water, saturated with sodium chloride and extracted with a mixture of diethyl ether and ethyl acetate. The combined extracts are washed with saturated sodium chloride solution, dried over magnesium sulphate and evaporated down. The flask residue is triturated with petroleum ether and the supernatant is decanted. The crude product is purified through a silica gel column with ethyl acetate as eluant.
Yield: 470 mg (68% of theory)
Rf value: 0.70 (silica gel, ethyl acetate)
Mass spectrum (ESI+): m/z=190 [M+H]+
The following compounds are obtained analogously to Example XLIX:
Rf value: 0.40 (silica gel, methylene chloride/methanol=10:1)
Mass spectrum (ESI+): m/z=190 [M+H]+
3.40 g of quinolin-5-ol is combined with 8 ml of conc. hydrochloric acid and 8 ml of 37% formalin solution while cooling with an ice bath. Then hydrogen chloride gas is piped through the reaction mixture for about two hours, while the temperature slowly rises. The reaction mixture is stirred first overnight while cooling with an ice bath, then at ambient temperature and then evaporated down in vacuo. The flask residue is taken up in water, covered with a layer of diethyl ether and adjusted to pH 10 while cooling with an ice bath and vigorously stirring with dilute ammonia solution. After another two hours' vigorous stirring at ambient temperature the organic phase is separated off and the aqueous phase is extracted with diethyl ether. The combined organic phases are washed with water and saturated sodium chloride solution, dried over magnesium sulphate and evaporated down. The flask residue is chromatographed through a silica gel column with methylene chloride/methanol (20:1) as eluant.
Yield: 660 mg (16% of theory)
Mass spectrum (ESI+): m/z=176 [M+H]+
The following compounds are obtained analogously to Example L:
Rf value: 0.50 (silica gel, methylene chloride/methanol=5:1)
Mass spectrum (ESI+): m/z=176 [M+H]+
A mixture of 250 mg of 1-(2-{2-[(cyclopropylcarbonyl)amino]-phenyl}-2-oxo-ethyl)-3-methyl-7-[(1-cyclopenten-1-yl)methyl]-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine and 7.5 ml of ethanolic ammonia solution (6 M) is heated to 150° C. for seven hours in a bomb. For working up the reaction mixture is evaporated down and chromatographed through a silica gel column with methylene chloride/methanol (100:0 to 70:30) as eluant. The contaminated product fraction is evaporated down and again purified through a reversed phase HPLC column with water/acetonitrile/trifluoroacetic acid (65:15:0.08 to 0:100:0.1) as eluant. The product fractions are evaporated down, made alkaline with dilute sodium hydroxide solution and extracted with methylene chloride. The combined extracts are dried over magnesium sulphate and evaporated down.
Yield: 40 mg (14% of theory)
Rf value: 0.40 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=627 [M+H]+
520 mg of 2-pyrrolidinone-hydrotribromide and 89 mg of 2-pyrrolidinone are added to 420 mg of 4-acetyl-1,3-bis-[(2-trimethylsilanyl-ethoxy)methyl]-1,3-dihydro-benzoimidazol-2-one in 5 ml of tetrahydrofuran under an argon atmosphere. The reaction mixture is refluxed for two hours and then suction filtered while still warm. The filter cake is washed with tetrahydrofuran and the filtrate is evaporated down, leaving 660 mg of a yellowish-brown solid. This is stirred with a little methanol, suction filtered, washed with some methanol and dried. The crude product is reacted further without any more purification.
Yield: 430 mg (87% of theory)
Rf value: 0.23 (silica gel, petroleum ether/ethyl acetate=9:1)
Mass spectrum (EI): m/z=514, 516 [M]+
The following compounds are obtained analogously to Example LII:
Rf value: 0.33 (silica gel, petroleum ether/ethyl acetate=9:1)
Mass spectrum (ESI+): m/z=338, 340 [M+H]+
(Carried out with phenyltrimethylammonium tribromide in methylene chloride)
Rf value: 0.39 (silica gel, cyclohexane/ethyl acetate=9:1)
(Carried out with phenyltrimethylammonium tribromide in methylene chloride)
Rf value: 0.24 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
A mixture of 1.91 g of 2-aminopyridine and 4.40 g of methyl 3-bromo-2-oxo-butyrate in 40 ml of ethanol is refluxed for 6 hours and then left to stand for 2 days at ambient temperature. The solvent is distilled off using the rotary evaporator and the crude product is purified by chromatography over a silica gel column with methylene chloride/methanol/methanolic ammonia solution (95:4:1 to 90:9:1) as eluant. 560 mg of the ethyl ester are isolated as the by-product.
Yield: 2.09 g (54% of theory)
Rf value: 0.20 (silica gel, methylene chloride/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=191 [M+H]+
Dry hydrogen chloride gas is piped through a solution of 2.86 g of 1-(2-amino-phenyl)-2-methyl-propan-1-one and 1.33 ml of chloroacetonitrile in 14 ml dioxane with stirring at ambient temperature for approx. five hours. Then the dioxane is largely distilled off in a water jet vacuum. The honey-like residue is combined with ice water and the resulting suspension is made alkaline with saturated potassium carbonate solution while cooling with an ice bath. The precipitate is suction filtered, washed with water and dried. The crude product is purified by chromatography over a silica gel column with petroleum ether/methylene chloride (8:2 to 0:1) as eluant.
Yield: 1.80 g (58% of theory)
Rf value: 0.30 (silica gel, methylene chloride/petroleum ether=1:1)
Mass spectrum (ESI+): m/z=221, 223 [M+H]+
530 mg of N-(1-benzyl-2,2,2-trifluoro-ethyl)-2-chloro-acetamide (prepared by reacting 1-benzyl-2,2,2-trifluoro-ethylamine with chloroacetyl chloride in the presence of triethylamine) and 0.74 ml of phosphorus oxychloride are added to 4.00 g of polyphosphoric acid. The viscous mixture is stirred for 1.5 hours at 130° C. For working up the reaction mixture is cooled and combined with ice water, stirred vigorously for ten minutes and suction filtered. The filter cake is dissolved in ethyl acetate and the solution is dried over magnesium sulphate and evaporated down, leaving a white solid.
Yield: 415 mg (84% of theory)
Rf value: 0.55 (aluminium oxide, petroleum ether/ethyl acetate=10:1)
Mass spectrum (ESI+): m/z=248, 250 [M+H]+
The following compound is obtained analogously to Example LV:
(The starting material N-(1-benzyl-2,2,2-trifluoro-ethyl)-acetamide is obtained by reacting 1-benzyl-2,2,2-trifluoro-ethylamine with acetic anhydride.)
A mixture of 375 mg of 1-(1-cyano-1-methyl-ethyl)-3-methyl-isoquinoline and 321 mg of N-bromosuccinimide in 5 ml carbon tetrachloride is combined with a spatula tip of 2,2-azoisobutyric acid dinitrile and refluxed for about six hours. The cooled reaction mixture is filtered and evaporated down. The flask residue is reacted further without any more purification.
Rf value: 0.70 (silica gel, cyclohexane/ethyl acetate=3:1)
The following compounds are obtained analogously to Example LVI:
Mass spectrum (ESI+): m/z=223, 225 [M+H]+
Rf value: 0.48 (silica gel, ethyl acetate/methanol=98:2)
Rf value: 0.85 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=299, 301 [M+H]+
Rf value: 0.56 (silica gel, methylene chloride/ethyl acetate=7:3)
Mass spectrum (ESI+): m/z=223, 225 [M+H]+
Mass spectrum (ESI+): m/z=290, 292 [M+H]+
Mass spectrum (ESI+): m/z=272, 274 [M+H]+
3.30 g of 2,2-azoisobutyric acid dinitrile are added to 1.60 g of 3-methyl-isoquinoline-N-oxide in 30 ml of toluene. The reaction mixture is stirred for six hours at 85° C. and then left to stand for two days at ambient temperature. For working up the reaction mixture is extracted with 20% hydrochloric acid. The combined aqueous phases are diluted with methylene chloride, made alkaline with saturated potassium carbonate solution while cooling with an ice bath and extracted with methylene chloride. The combined methylene chloride extracts are dried over magnesium sulphate and evaporated down. The residue is chromatographed through a silica gel column with cyclohexane as eluant.
Yield: 375 mg (18% of theory)
Mass spectrum (ESI+): m/z=211 [M+H]+
Rf value: 0.75 (silica gel, cyclohexane/ethyl acetate=3:1)
0.48 ml of a 1M solution of titanium tetrachloride in methylene chloride are added dropwise to 244 mg of 1-(2-phenyl-2-oxo-ethyl)-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxy-carbonylamino)-piperidin-1-yl]-xanthine in 7 ml of methylene chloride. Then 88 μl of 1,3-bis(trimethylsilyl)carbodiimide are added and the mixture is stirred for four hours at ambient temperature. For working up the reaction mixture is diluted with methylene chloride and poured onto ice water. The organic phase is washed with 0.5 N citric acid, dried over magnesium sulphate and evaporated down. The crude product is purified by chromatography over a silica gel column with methylene chloride/methanol (98:2 to 95:5) as eluant.
Yield: 206 mg (97% of theory)
Mass spectrum (ESI−): m/z=557 [M−H]−
Rf value: 0.16 (silica gel, cyclohexane/ethyl acetate=1:1)
350 mg of 1-[(2-amino-phenylaminocarbonyl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine are refluxed in 3 ml glacial acetic acid for two hours. Then the reaction mixture is evaporated down, the flask residue is combined with 5 ml of 1 M sodium hydroxide solution and washed with methylene chloride. Then the aqueous phase is acidified with 1 M hydrochloric acid and extracted with methylene chloride. The combined extracts are evaporated down and chromatographed through a silica gel column with cyclohexane/ethyl acetate/methanol (6:4:0 to 5:4:1) as eluant.
Yield: 250 mg of (74% of theory)
Mass spectrum (ESI+): m/z=547 [M+H]+
Prepared by treating 1.16 g of ethyl 3,4-dimethyl-4a-(pyrrolidin-1-yl)-5,6,7,7a-tetrahydro-4aH-[2]pyrindin-1-carboxylate with 1.08 g of 70% 3-chloro-perbenzoic acid in 50 ml methylene chloride at ambient temperature.
Yield: 850 mg (97% of theory)
Rf value: 0.30 (aluminium oxide, petroleum ether/ethyl acetate=5:1)
Mass spectrum (ESI+): m/z=220 [M+H]+
The following compounds are obtained analogously to Example LX:
Rf value: 0.35 (aluminium oxide, petroleum ether/ethyl acetate=5:1)
Mass spectrum (ESI+): m/z=234 [M+H]+
Prepared by reacting 2.50 g of ethyl 5,6-dimethyl-[1,2,4]triazin-3-carboxylate with 2.74 g of 1-(cyclopenten-1-yl)-pyrrolidine in 25 ml chloroform at ambient temperature.
Yield: 3.00 g (75% of theory)
Rf value: 0.60 (aluminium oxide, petroleum ether/ethyl acetate=5:1)
Mass spectrum (ESI+): m/z=291 [M+H]+
The following compounds are obtained analogously to Example LXI:
Rf value: 0.60 (aluminium oxide, petroleum ether/ethyl acetate=5:1)
Mass spectrum (ESI+): m/z=305 [M+H]+
Prepared by reacting 1.60 g of methyl 3,4-diamino-5-methyl-benzoate with 0.86 ml diacetyl in a mixture of water and ethanol while refluxing.
Yield: 1.53 g (80% of theory)
Rf value: 0.63 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=231 [M+H]+
The following compounds are obtained analogously to Example LXII:
(reaction is carried out with glyoxal in water.)
Rf value: 0.55 (silica gel, cyclohexane/ethyl acetate=1:1)
Mass spectrum (ESI+): m/z=203 [M+H]+
(reaction is carried out with glyoxal in a water/ethanol mixture.)
Rf value: 0.75 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=223, 225 [M+H]+
Prepared by reduction of methyl 3-nitro-4-amino-5-methyl-benzoate at a partial hydrogen pressure of 50 psi in the presence of Raney nickel in methanol at ambient temperature.
Rf value: 0.40 (silica gel, tert.-butylmethylether)
Prepared by treating 3-nitro-4-acetylamino-5-methyl-benzoic acid with hydrogen chloride gas in methanol at ambient temperature and subsequently heating while refluxing.
Mass spectrum (ESI+): m/z=211 [M+H]+
Rf value: 0.75 (silica gel, tert.-butylmethylether/acetic acid=99:1)
0.13 ml 35% hydrogen peroxide solution are added to 290 mg of 1-(2-phenyl-2-oxo-ethyl)-3-methyl-7-(1-phenylsulphanyl-butyl)-8-bromo-xanthine in 6 ml hexafluoroisopropanol. The reaction mixture is stirred for one hour at ambient temperature, diluted with methylene chloride and washed with sodium thiosulphate solution. The organic phase is dried over magnesium sulphate and evaporated down. The flask residue is taken up in 6 ml of toluene and refluxed for eight hours. Then the toluene is distilled off in vacuo and the crude product is purified through a silica gel column with methylene chloride/methanol (100:0 to 95:5) as eluant.
Yield: 104 mg (45% of theory)
Rf value: 0.61 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=417, 419 [M+H]+
The following compounds are obtained analogously to Example LXV:
Rf value: 0.24 (silica gel, methylene chloride/methanol=95:5)
Mass spectrum (ESI+): m/z=313, 315 [M+H]+
Prepared by reacting (4-difluoromethoxy-naphthalen-1-yl)-methanol with methanesulphonic acid chloride in methylene chloride in the presence of triethylamine.
The following compounds are obtained analogously to Example LXVI:
A mixture of 400 mg of 5-bromo-7-methyl-quinoxaline, 244 mg of phenylboric acid and 100 mg of tetrakis(triphenylphosphine)palladium in 12 ml dioxane, 4 ml of methanol and 3.6 ml 1 M aqueous sodium carbonate solution is refluxed for three hours under an argon atmosphere. Then the reaction mixture is evaporated down and the residue is distributed between ethyl acetate and water. The ethyl acetate phase is separated off, dried over magnesium sulphate and evaporated down. The crude product is purified by chromatography over a silica gel column with cyclohexane/ethyl acetate (85:15 to 70:30) as eluant.
Yield: 390 mg (66% of theory)
Rf value: 0.36 (silica gel, petroleum ether/ethyl acetate=5:1)
Mass spectrum (ESI+): m/z=221 [M+H]+
Prepared by treating 905 mg of 1-chloromethyl-3-trifluoromethyl-3,4-dihydro-isoquinoline with 420 mg of potassium-tert. butoxide in 10 ml of tetrahydrofuran at ambient temperature.
Yield: 755 mg of (98% of theory)
Mass spectrum (ESI+): m/z=212 [M+H]+
The following compounds are obtained analogously to Example LXVIII:
(Prepared from 1-methyl-3-trifluoromethyl-3,4-dihydro-isoquinoline)
Mass spectrum (ESI+): m/z=194 [M+H]+
Prepared by treating 3-methoxy-1-methyl-isoquinoline with sulphuryl chloride in methylene chloride.
Rf value: 0.30 (silica gel, cyclohexane)
Mass spectrum (ESI+): m/z=208, 210 [M+H]+
Prepared by reacting 3-cyclopropyl-xanthine with bromine in the presence of potassium carbonate in acetonitrile at 60° C.
Rf value: 0.65 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=271, 273 [M+H]+
Analogously to the method described by Gonsalves et al. (Tetrahedron 1992, 48, 6821) a solution of 3.90 g of ethyl 5,6,7,8-tetrahydro-benzo[1,2,4]triazin-3-carboxylate (Sagi et al., Heterocycles 1989, 29, 2253) in 20 ml dioxane is refluxed. Then 8.22 g of anthranilic acid and 7.02 g of isoamylnitrite, in each case dissolved in 20 ml dioxane, are simultaneously added dropwise within 25 minutes by means of two dropping funnels. The reaction mixture is refluxed for a further 30 minutes. For working up the cooled deep-brown reaction solution is diluted with 150 ml diethyl ether, washed with 100 ml of 2 N sodium hydroxide solution and with water, dried over magnesium sulphate and evaporated down. The brown, oily flask residue is chromatographed through a silica gel column with ethyl acetate/petroleum ether (20:80 to 50:50) as eluant. The product obtained is still somewhat contaminated, but is reacted further without any more purification.
Yield: 380 mg (8% of theory)
Rf value: 0.55 (silica gel, petroleum ether/ethyl acetate=2:1)
Mass spectrum (ESI+): m/z=256 [M+H]+
Preparation of the final compounds:
129 mg of 3-amino-piperidine-dihydrochloride are added to a mixture of 298 mg of 1,3-dimethyl-7-(2,6-dicyano-benzyl)-8-bromo-xanthine and 420 mg of potassium carbonate in 9 ml of N,N-dimethylformamide. The reaction mixture is stirred for three hours at 80° C. For working up the mixture is diluted with methylene chloride and washed with saturated sodium chloride solution. The organic phase is dried over magnesium sulphate and evaporated down. The crude product is purified by chromatography through a silica gel column with methylene chloride/methanol/conc. methanolic ammonia (95:5:1 to 80:20:1) as eluant.
Yield: 43 mg (14% of theory)
Rf value: 0.67 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=80:20:1)
Mass spectrum (ESI+): m/z=419 [M+H]+
The following compounds are obtained analogously to Example 1:
Rf value: 0.35 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=433 [M+H]+
A solution of 209 mg of 1-(2-{2-[(ethoxycarbonyl)methoxy]-phenyl}-2-oxo-ethyl)-3-methyl-7-(3-methyl-2-buten-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine in 4 ml methylene chloride is combined with 1 ml of trifluoroacetic acid and stirred for half an hour at ambient temperature. For working up the reaction mixture is diluted with methylene chloride and washed with saturated potassium carbonate solution. The organic phase is dried, evaporated down and chromatographed through a silica gel column with methylene chloride/methanol (1:0 to 4:1) as eluant.
Yield: 153 mg of (87% of theory)
Mass spectrum (ESI+): m/z=553 [M+H]+
The following compounds are obtained analogously to Example 2:
Mass spectrum (ESI+): m/z=524 [M+H]+
Rf value: 0.58 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=100:100:0.1)
Mass spectrum (ESI+): m/z=543 [M+H]+
Mass spectrum (ESI+): m/z=465 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=500 [M+H]+
Rf value: 0.58 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=80:20:1)
Mass spectrum (ESI−): m/z=435 [M−H]−
Mass spectrum (ESI+): m/z=553 [M+H]+
Mass spectrum (ESI+): m/z=538 [M+H]+
Mass spectrum (ESI+): m/z=552 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=438 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=452 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.20 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=419 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=418 [M+H]+
Rf value: 0.54 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=100:100:0.1)
Mass spectrum (ESI+): m/z=535 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=420 [M+H]+
Mass spectrum (ESI+): m/z=435 [M+H]+
Rf value: 0.50 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=100:100:0.1)
Mass spectrum (ESI+): m/z=522 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=456 [M+H]+
Rf value: 0.50 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=466 [M+H]+
Rf value: 0.07 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=476 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=474 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=491 [M+H]+
Rf value: 0.16 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.49 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=475 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 178-181° C.
Mass spectrum (ESI+): m/z=504 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.06 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=491 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.48 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=475 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.40 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=504 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.51 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=474 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.23 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:1)
Mass spectrum (ESI+): m/z=491 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.51 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=500 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.58 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=500 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product precipitated as the hydrochloride)
Rf value: 0.55 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=505 [M+H]+
Rf value: 0.34 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=497 [M+H]+
Rf value: 0.21 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=513 [M+H]+
Rf value: 0.66 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=529 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product precipitated as the hydrochloride)
Rf value: 0.54 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=495 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product precipitated as the hydrochloride)
Rf value: 0.47 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=509 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.53 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=508 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.53 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=522 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.53 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=564 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.53 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=495 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.41 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=523 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.53 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=522 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.53 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=564 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.44 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=511 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; product obtained as the hydrochloride)
Rf value: 0.68 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=465 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.38 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=449 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.51 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=479 [M+H]+
Rf value: 0.48 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=462 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.30 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=499 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.56 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=457 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.40 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=488 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.52 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=458 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.48 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=457 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.49 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=431 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.20 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=459 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.25 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=471 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.43 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=561 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.38 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=418 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.35 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=458 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.17 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=488 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.13 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=504 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.17 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=487 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.42 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=458 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.14 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=487 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 155-158° C.
Mass spectrum (ESI+): m/z=472 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.40 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=511 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.15 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=502 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.56 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=444 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.46 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=472 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.20 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=457 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.38 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=475 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.15 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=458 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.18 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=500 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; the product still contains approx. 20% of Z isomer)
Rf value: 0.66 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=460 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.25 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=487 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=509 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.20 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=489 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.47 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=522 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=495 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=459 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=459 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; the product still contains approx. 20% of Z isomer)
Rf value: 0.12 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; the product still contains approx. 15% of Z isomer)
Rf value: 0.12 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:0.1)
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; the product still contains approx. 17% of Z isomer)
Rf value: 0.54 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=474 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride; the product still contains approx. 17% of Z isomer)
Rf value: 0.54 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=474 [M+H]+
Mass spectrum (ESI+): m/z=536 [M+H]+
Mass spectrum (ESI+): m/z=478 [M+H]+
Mass spectrum (ESI+): m/z=463 [M+H]+
Mass spectrum (ESI+): m/z=550 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=422 [M+H]+
Mass spectrum (ESI+): m/z=522 [M+H]+
Mass spectrum (ESI+): m/z=508 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=505 [M+H]+
Rf value: 0.30 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=550 [M+H]+
Rf value: 0.21 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=532 [M+H]+
(product contains approx. 10% of Z isomer)
Mass spectrum (ESI+): m/z=494 [M+H]+
(product contains approx. 25% of Z isomer)
Rf value: 0.30 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=437 [M+H]+
Mass spectrum (ESI+): m/z=567 [M+H]+
Mass spectrum (ESI+): m/z=522 [M+H]+
(product contains approx. 10% of Z isomer)
Mass spectrum (ESI+): m/z=522 [M+H]+
(product contains approx. 8% of Z isomer)
Rf value: 0.51 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=524 [M+H]+
Mass spectrum (ESI+): m/z=536 [M+H]+
Mass spectrum (ESI+): m/z=581 [M+H]+
Rf value: 0.54 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=452 [M+H]+
Rf value: 0.48 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=508 [M+H]+
Rf value: 0.31 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=450 [M+H]+
Mass spectrum (ESI+): m/z=522 [M+H]+
(product contains approx. 22% of Z isomer)
Mass spectrum (ESI+): m/z=437 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=536 [M+H]+
Rf value: 0.23 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=492 [M+H]+
Rf value: 0.20 (silica gel, methylene chloride/methanol=9:1)
Mass spectrum (ESI+): m/z=562 [M+H]+
Mass spectrum (ESI+): m/z=538 [M+H]+
Mass spectrum (ESI+): m/z=435 [M+H]+
(product contains approx. 30% of Z isomer)
Mass spectrum (ESI+): m/z=538 [M+H]+
Mass spectrum (ESI+): m/z=380 [M+H]+
Rf value: 0.40 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=536 [M+H]+
(product contains approx. 23% of Z isomer)
Rf value: 0.42 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=437 [M+H]+
Rf value: 0.20 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=520 [M+H]+
Rf value: 0.15 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=492 [M+H]+
Mass spectrum (ESI+): m/z=520 [M+H]+
Rf value: 0.21 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=437 [M+H]+
Rf value: 0.14 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=501, 503 [M+H]+
Rf value: 0.42 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=524 [M+H]+
Rf value: 0.23 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=463 [M+H]+
Rf value: 0.18 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=537 [M+H]+
Mass spectrum (ESI+): m/z=522 [M+H]+
Mass spectrum (ESI+): m/z=435 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 155-156.5° C.
Mass spectrum (ESI+): m/z=472 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.52 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=472 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.46 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=472 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.46 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=472 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.48 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=474 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 167.5-172° C.
Mass spectrum (ESI+): m/z=474 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.34 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=493 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=493 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.52 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=487 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.52 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=487 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.41 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=479 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=479 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.51 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=473 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 198-202° C.
Mass spectrum (ESI+): m/z=473 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.53 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=522 [M+H]+
Mass spectrum (ESI+): m/z=538 [M+H]+
Rf value: 0.49 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=522 [M+H]+
Mass spectrum (ESI+): m/z=508 [M+H]+
Mass spectrum (ESI+): m/z=494 [M+H]+
Mass spectrum (ESI+): m/z=524 [M+H]+
Rf value: 0.49 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=494 [M+H]+
Mass spectrum (ESI+): m/z=524 [M+H]+
Mass spectrum (ESI+): m/z=520 [M+H]+
Mass spectrum (ESI+): m/z=522 [M+H]+
Mass spectrum (ESI+): m/z=578 [M+H]+
Rf value: 0.50 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=508 [M+H]+
Mass spectrum (ESI+): m/z=506 [M+H]+
Rf value: 0.20 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=506 [M+H]+
Mass spectrum (ESI+): m/z=492 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.49 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=526 [M+H]+
Rf value: 0.49 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=556 [M+H]+
(Obtained as main product when 1-{2-[2-(2-oxo-propoxy)-phenyl]-2-oxo-ethyl}-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine is treated with trifluoroacetic acid in methylene chloride)
Mass spectrum (ESI+): m/z=489 [M+H]+
Mass spectrum (ESI+): m/z=565 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.38 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=496 [M+H]+
Rf value: 0.30 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=502 [M+H]+
Rf value: 0.42 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=508 [M+H]+
Rf value: 0.51 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=538 [M+H]+
Rf value: 0.29 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=451 [M+H]+
Rf value: 0.59 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=80:20:1)
Mass spectrum (ESI+): m/z=451 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.47 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=447 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=459 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.55 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=519 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=459 [M+H]+
Mass spectrum (ESI+): m/z=472 [M+H]+
Mass spectrum (ESI+): m/z=492 [M+H]+
Rf value: 0.47 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Melting point: 188.5-191° C.
Mass spectrum (ESI+): m/z=473 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.45 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=534 [M+H]+
Mass spectrum (ESI+): m/z=527 [M+H]+
(Produced when 1-{[2-(tert.-butylcarbonyl)-benzofuran-3-yl]methyl}-3-methyl-7-(2-butyn-1-yl)-8-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine is treated with trifluoroacetic acid in methylene chloride)
Mass spectrum (ESI+): m/z=447 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.75 (aluminium oxide, methylene chloride/methanol=10:1)
Mass spectrum (ESI+): m/z=486 [M+H]+
Mass spectrum (ESI+): m/z=447 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.45 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=544 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.55 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=542 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.23 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=543 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=528 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.43 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=505 [M+H]+
Rf value: 0.27 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=482 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.37 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=447 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.46 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.40 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=474 [M+H]+
Mass spectrum (ESI+): m/z=437 [M+H]+
Rf value: 0.45 (silica gel, methylene chloride/methanol=5:1)
Mass spectrum (ESI+): m/z=488 [M+H]+
Rf value: 0.20 (silica gel, ethyl acetate/methanol=1:1)
Mass spectrum (ESI+): m/z=488 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.60 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=535 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.48 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.55 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=527 [M+H]+
Mass spectrum (ESI+): m/z=463 [M+H]+
Rf value: 0.52 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=523 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=491 [M+H]+
Rf value: 0.75 (silica gel, methylene chloride/methanol=10:1)
Mass spectrum (ESI+): m/z=508 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.80 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=96:4:0.5)
Mass spectrum (ESI+): m/z=515 [M+H]+
Rf-Wet: 0.45 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=515 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.53 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 176.5-178° C.
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 201-204° C.
Mass spectrum (ESI+): m/z=537 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=501 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.65 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=465 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.60 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=460 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=458 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=523 [M+H]+
Rf value: 0.55 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=446 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.60 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=485 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol=5:1)
Mass spectrum (ESI+): m/z=488 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.25 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=525 [M+H]+
Mass spectrum (ESI+): m/z=459 [M+H]+
Mass spectrum (ESI+): m/z=447 [M+H]+
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=535 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=487 [M+H]+
Rf value: 0.35 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:0.1)
Mass spectrum (ESI+): m/z=461 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=535 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.48 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=486 [M+H]+
Rf value: 0.25 (aluminium oxide, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=476 [M+H]+
Rf value: 0.50 (aluminium oxide, methylene chloride/methanol=20:1)
Mass spectrum (ESI+): m/z=490 [M+H]+
Rf value: 0.52 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=474 [M+H]+
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=447 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.47 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=447 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.40 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=488 [M+H]+
Rf value: 0.23 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=474 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.37 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=501 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.35 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=473 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.55 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=473 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.40 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=566, 568 [M+H]+
Rf value: 0.31 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=437 [M+H]+
Rf value: 0.08 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=95:5:1)
Mass spectrum (ESI+): m/z=523 [M+H]+
Rf value: 0.46 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=474 [M+H]+
Mass spectrum (ESI+): m/z=478 [M+H]+
Mass spectrum (ESI+): m/z=523 [M+H]+
Rf value: 0.38 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=502 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.55 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=500 [M+H]+
Mass spectrum (ESI+): m/z=518 [M+H]+
Rf value: 0.47 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=537 [M+H]+
Rf value: 0.50 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=448 [M+H]+
Rf value: 0.49 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=493 [M+H]+
Rf value: 0.21 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=488 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.55 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=458 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.51 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=459 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.49 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=473 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.46 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=501 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=459 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.45 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=459 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=475 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=459 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 187-189° C.
Mass spectrum (ESI+): m/z=506 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=535 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.52 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=459 [M+H]+
Mass spectrum (ESI+): m/z=523 [M+H]+
Mass spectrum (ESI+): m/z=501 [M+H]+
Mass spectrum (ESI+): m/z=501 [M+H]+
Mass spectrum (ESI+): m/z=501 [M+H]+
Mass spectrum (ESI+): m/z=526 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.51 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=535 [M+H]+
Mass spectrum (ESI+): m/z=508 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Mass spectrum (ESI+): m/z=522, 524 [M+H]+
Rf value: 0.40 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
(Carried out with 1 M ethereal hydrochloric acid)
Rf value: 0.60 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=503 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.55 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=517 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 167° C.
Mass spectrum (ESI+): m/z=478 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.45 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=534 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.60 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=551 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.45 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=561 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.55 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=498 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=535 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.29 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=465 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.27 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=465 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.29 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=519 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.35 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=511 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.35 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=511 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.20 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=493 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.50 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=498 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.45 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=561 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Melting point: 191° C.
Mass spectrum (ESI+): m/z=508 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.40 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:1)
Mass spectrum (ESI+): m/z=527 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.29 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=479 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.28 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=465 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.34 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=465 [M+H]+
Mass spectrum (ESI+): m/z=544, 546 [M+H]+
Mass spectrum (ESI+): m/z=588, 590 [M+H]+
Rf value: 0.75 (aluminium oxide, methylene chloride/methanol=10:1)
Mass spectrum (ESI+): m/z=512 [M+H]+
(Carried out with 5-6 M isopropanolic hydrochloric acid in methylene chloride)
Rf value: 0.28 (silica gel, methylene chloride/methanol/conc. aqueous ammonia=90:10:1)
Mass spectrum (ESI+): m/z=501 [M+H]+
Rf value: 0.35 (silica gel, methylene chloride/methanol/triethylamine=90:10:1)
Mass spectrum (ESI+): m/z=545, 547 [M+H]+
Rf value: 0.40 (silica gel, methylene chloride/methanol/triethylamine=90:10:1)
Mass spectrum (ESI+): m/z=607, 609 [M+H]+
Prepared by saponifying 70 mg of 1-(2-{3-[(methoxycarbonyl)methoxy]-phenyl}-2-oxo-ethyl)-3-methyl-7-(3-methyl-2-buten-1-yl)-8-(3-amino-piperidin-1-yl)-xanthine with 0.10 ml of 4 M potassium hydroxide solution in a mixture of 1 ml of tetrahydrofuran and 0.5 ml of methanol at ambient temperature.
Yield: 57 mg (84% of theory)
Rf value: 0.55 (ready-made reversed phase TLC plate (E. Merck), acetonitrile/water/trifluoroacetic acid=50:50:0.1)
Mass spectrum (ESI+): m/z=525 [M+H]+
The following compounds are obtained analogously to Example 3:
(Carried out with sodium hydroxide solution)
Mass spectrum (ESI−): m/z=523 [M−H]−
Preparation:
The active substance is mixed with calcium phosphate, corn starch, polyvinylpyrrolidone, hydroxypropylmethylcellulose and half the specified amount of magnesium stearate. Blanks 13 mm in diameter are produced in a tablet-making machine and these are then rubbed through a screen with a mesh size of 1.5 mm using a suitable machine and mixed with the rest of the magnesium stearate. This granulate is compressed in a tablet-making machine to form tablets of the desired shape.
The tablet cores thus produced are coated with a film consisting essentially of hydroxypropylmethylcellulose. The finished film-coated tablets are polished with beeswax.
Method of Preparation:
The active substance, lactose and starch are mixed together and uniformly moistened with an aqueous solution of the polyvinylpyrrolidone. After the moist composition has been screened (2.0 mm mesh size) and dried in a rack-type drier at 50° C. it is screened again (1.5 mm mesh size) and the lubricant is added. The finished mixture is compressed to form tablets.
Preparation:
The active substance mixed with lactose, corn starch and silica is moistened with a 20% aqueous polyvinylpyrrolidone solution and passed through a screen with a mesh size of 1.5 mm. The granules, dried at 45° C., are passed through the same screen again and mixed with the specified amount of magnesium stearate. Tablets are pressed from the mixture.
Preparation:
The active substance is mixed with the excipients, passed through a screen with a mesh size of 0.75 mm and homogeneously mixed using a suitable apparatus. The finished mixture is packed into size 1 hard gelatine capsules.
Preparation:
After the suppository mass has been melted the active substance is homogeneously distributed therein and the melt is poured into chilled moulds.
Preparation:
The distilled water is heated to 70° C. The methyl and propyl p-hydroxybenzoates together with the glycerol and sodium salt of carboxymethylcellulose are dissolved therein with stirring. The solution is cooled to ambient temperature and the active substance is added and homogeneously dispersed therein with stirring. After the sugar, the sorbitol solution and the flavouring have been added and dissolved, the suspension is evacuated with stirring to eliminate air.
Preparation:
The active substance is dissolved in the necessary amount of 0.01 N HCl, made isotonic with common salt, filtered sterile and transferred into 2 ml ampoules.
Preparation:
The active substance is dissolved in the necessary amount of 0.01 N HCl, made isotonic with common salt, filtered sterile and transferred into 10 ml ampoules.
| Number | Date | Country | Kind |
|---|---|---|---|
| 102 38 243 | Aug 2002 | DE | national |
| 103 12 353 | Mar 2003 | DE | national |
This application is a continuation of Ser. No. 10/639,036, filed Aug. 12, 2003. This application claims benefit to U.S. provisional application Ser. Nos. 60/409,312 filed Sep. 9, 2002, and 60/461,752 filed Apr. 10, 2003, and German application nos. DE 102 38 243.3 filed Aug. 21, 2002, and DE 103 12 353.9 filed Mar. 20, 2003.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2056046 | Fourneau | Sep 1936 | A |
| 2375138 | Victors | May 1945 | A |
| 2629736 | Krimmel | Feb 1953 | A |
| 2730544 | Sahyun | Jan 1956 | A |
| 2750387 | Krimmel | Jun 1956 | A |
| 2928833 | Leake et al. | Mar 1960 | A |
| 3174901 | Sterne | Mar 1965 | A |
| 3236891 | Seemuller | Feb 1966 | A |
| 3454635 | Muth | Jul 1969 | A |
| 3673241 | Marxer | Jun 1972 | A |
| 3925357 | Okada et al. | Dec 1975 | A |
| 4005208 | Bender | Jan 1977 | A |
| 4061753 | Bodor et al. | Dec 1977 | A |
| 4599338 | Regnier et al. | Jul 1986 | A |
| 4639436 | Junge et al. | Jan 1987 | A |
| 4687777 | Meguro et al. | Aug 1987 | A |
| 4873330 | Lindholm | Oct 1989 | A |
| 4968672 | Jacobson et al. | Nov 1990 | A |
| 5041448 | Janssens | Aug 1991 | A |
| 5051517 | Findeisen | Sep 1991 | A |
| 5084460 | Munson, Jr. et al. | Jan 1992 | A |
| 5219870 | Kim | Jun 1993 | A |
| 5223499 | Greenlee | Jun 1993 | A |
| 5234897 | Findeisen et al. | Aug 1993 | A |
| 5258380 | Janssens | Nov 1993 | A |
| 5266555 | Findeisen et al. | Nov 1993 | A |
| 5273995 | Roth | Dec 1993 | A |
| 5300298 | LaNoue | Apr 1994 | A |
| 5329025 | Wong et al. | Jul 1994 | A |
| 5332744 | Chakravarty et al. | Jul 1994 | A |
| 5389642 | Dorsch | Feb 1995 | A |
| 5399578 | Buhlmayer et al. | Mar 1995 | A |
| 5407929 | Takahashi et al. | Apr 1995 | A |
| 5470579 | Bonte et al. | Nov 1995 | A |
| 5602127 | Hauel et al. | Feb 1997 | A |
| 5719279 | Kuefner-Muhl et al. | Feb 1998 | A |
| 5728849 | Bouchard et al. | Mar 1998 | A |
| 5753635 | Buckman | May 1998 | A |
| 5958951 | Ahrndt et al. | Sep 1999 | A |
| 5965555 | Gebert et al. | Oct 1999 | A |
| 5965592 | Buhlmayer et al. | Oct 1999 | A |
| 6107302 | Carter et al. | Aug 2000 | A |
| 6248758 | Klokkers et al. | Jun 2001 | B1 |
| 6303661 | Demuth | Oct 2001 | B1 |
| 6342601 | Bantick | Jan 2002 | B1 |
| 6372940 | Cavazza | Apr 2002 | B1 |
| 6548481 | Demuth et al. | Apr 2003 | B1 |
| 6579868 | Asano | Jun 2003 | B1 |
| 6727261 | Gobbi et al. | Apr 2004 | B2 |
| 6784195 | Hale et al. | Aug 2004 | B2 |
| 6821978 | Chackalamannil | Nov 2004 | B2 |
| 6869947 | Kanstrup | Mar 2005 | B2 |
| 7060722 | Kitajima | Jun 2006 | B2 |
| 7074794 | Kitajima | Jul 2006 | B2 |
| 7074798 | Yoshikawa | Jul 2006 | B2 |
| 7074923 | Dahanukar | Jul 2006 | B2 |
| 7109192 | Hauel | Sep 2006 | B2 |
| 7179809 | Eckhardt | Feb 2007 | B2 |
| 7183280 | Himmelsbach | Feb 2007 | B2 |
| 7192952 | Kanstrup | Mar 2007 | B2 |
| 7217711 | Eckhardt | May 2007 | B2 |
| 7235538 | Kanstrup et al. | Jun 2007 | B2 |
| 7291642 | Kauffmann-Hefner et al. | Nov 2007 | B2 |
| 7361687 | Barth et al. | Apr 2008 | B2 |
| 7393847 | Eckhardt et al. | Jul 2008 | B2 |
| 7407955 | Himmelsbach et al. | Aug 2008 | B2 |
| 7432262 | Eckhardt et al. | Oct 2008 | B2 |
| 7439370 | Eckhardt | Oct 2008 | B2 |
| 7470716 | Eckhardt et al. | Dec 2008 | B2 |
| 7476671 | Eckhardt et al. | Jan 2009 | B2 |
| 7482337 | Himmelsbach et al. | Jan 2009 | B2 |
| 7495002 | Langkopf et al. | Feb 2009 | B2 |
| 7495003 | Eckhardt et al. | Feb 2009 | B2 |
| 7495005 | Himmelsbach et al. | Feb 2009 | B2 |
| 7501426 | Himmelsbach et al. | Mar 2009 | B2 |
| 7550455 | Himmelsbach et al. | Jun 2009 | B2 |
| 7560450 | Eckhardt et al. | Jul 2009 | B2 |
| 7566707 | Eckhardt et al. | Jul 2009 | B2 |
| 7569574 | Maier et al. | Aug 2009 | B2 |
| 7579449 | Eckhardt et al. | Aug 2009 | B2 |
| 7645763 | Himmelsbach et al. | Jan 2010 | B2 |
| 7718666 | Boehringer et al. | May 2010 | B2 |
| 7820815 | Pfrengle et al. | Oct 2010 | B2 |
| 8106060 | Pfrengle et al. | Jan 2012 | B2 |
| 8119648 | Himmelsbach et al. | Feb 2012 | B2 |
| 20010020006 | Demuth et al. | Sep 2001 | A1 |
| 20010051646 | Demuth et al. | Dec 2001 | A1 |
| 20020137903 | Ellsworth et al. | Sep 2002 | A1 |
| 20020161001 | Kanstrup | Oct 2002 | A1 |
| 20020169174 | Chackalamannil et al. | Nov 2002 | A1 |
| 20020198205 | Himmelsbach | Dec 2002 | A1 |
| 20030105077 | Kanstrup et al. | Jun 2003 | A1 |
| 20030114390 | Washburn et al. | Jun 2003 | A1 |
| 20030166578 | Arch et al. | Sep 2003 | A1 |
| 20030199528 | Kanstrup | Oct 2003 | A1 |
| 20030224043 | Appel et al. | Dec 2003 | A1 |
| 20030232987 | Dahanukar et al. | Dec 2003 | A1 |
| 20030236272 | Carr | Dec 2003 | A1 |
| 20040023981 | Ren et al. | Feb 2004 | A1 |
| 20040034014 | Kanstrup et al. | Feb 2004 | A1 |
| 20040063725 | Barth et al. | Apr 2004 | A1 |
| 20040077645 | Himmelsbach et al. | Apr 2004 | A1 |
| 20040082570 | Yoshikawa | Apr 2004 | A1 |
| 20040087587 | Himmelsbach | May 2004 | A1 |
| 20040097510 | Himmelsbach et al. | May 2004 | A1 |
| 20040116328 | Yoshikawa et al. | Jun 2004 | A1 |
| 20040122228 | Maier | Jun 2004 | A1 |
| 20040126358 | Warne et al. | Jul 2004 | A1 |
| 20040138214 | Himmelsbach et al. | Jul 2004 | A1 |
| 20040138215 | Eckhardt | Jul 2004 | A1 |
| 20040166125 | Himmelsbach | Aug 2004 | A1 |
| 20040180925 | Matsuno et al. | Sep 2004 | A1 |
| 20050020574 | Hauel et al. | Jan 2005 | A1 |
| 20050026921 | Eckhardt | Feb 2005 | A1 |
| 20050032804 | Cypes et al. | Feb 2005 | A1 |
| 20050070594 | Kauschke et al. | Mar 2005 | A1 |
| 20050130985 | Himmelsbach | Jun 2005 | A1 |
| 20050143377 | Himmelsbach et al. | Jun 2005 | A1 |
| 20050171093 | Eckhardt et al. | Aug 2005 | A1 |
| 20050187227 | Himmelsbach et al. | Aug 2005 | A1 |
| 20050203095 | Eckhardt | Sep 2005 | A1 |
| 20050234108 | Himmelsbach et al. | Oct 2005 | A1 |
| 20050234235 | Eckhardt et al. | Oct 2005 | A1 |
| 20050239778 | Konetzki et al. | Oct 2005 | A1 |
| 20050256310 | Hulin et al. | Nov 2005 | A1 |
| 20050261352 | Eckhardt | Nov 2005 | A1 |
| 20050266080 | Desai et al. | Dec 2005 | A1 |
| 20050276794 | Papas et al. | Dec 2005 | A1 |
| 20060004074 | Eckhardt | Jan 2006 | A1 |
| 20060039974 | Akiyama et al. | Feb 2006 | A1 |
| 20060047125 | Leonardi et al. | Mar 2006 | A1 |
| 20060058323 | Eckhardt et al. | Mar 2006 | A1 |
| 20060063787 | Yoshikawa | Mar 2006 | A1 |
| 20060079541 | Langkopf | Apr 2006 | A1 |
| 20060094722 | Yasuda | May 2006 | A1 |
| 20060100199 | Yoshikawa et al. | May 2006 | A1 |
| 20060111379 | Guillemont et al. | May 2006 | A1 |
| 20060142310 | Pfrengle et al. | Jun 2006 | A1 |
| 20060154866 | Chu et al. | Jul 2006 | A1 |
| 20060173056 | Kitajima | Aug 2006 | A1 |
| 20060205711 | Himmelsbach | Sep 2006 | A1 |
| 20060205943 | Dahanukar et al. | Sep 2006 | A1 |
| 20060247226 | Himmelsbach | Nov 2006 | A1 |
| 20060270668 | Chew et al. | Nov 2006 | A1 |
| 20070027168 | Pfrengle et al. | Feb 2007 | A1 |
| 20070060530 | Christopher et al. | Mar 2007 | A1 |
| 20070088038 | Eckhardt | Apr 2007 | A1 |
| 20070093659 | Bonfanti | Apr 2007 | A1 |
| 20070142383 | Eckhardt | Jun 2007 | A1 |
| 20070185091 | Himmelsbach et al. | Aug 2007 | A1 |
| 20070196472 | Kiel et al. | Aug 2007 | A1 |
| 20070219178 | Muramoto | Sep 2007 | A1 |
| 20070259900 | Sieger | Nov 2007 | A1 |
| 20070281940 | Dugi | Dec 2007 | A1 |
| 20070299076 | Piotrowski et al. | Dec 2007 | A1 |
| 20080039427 | Ray et al. | Feb 2008 | A1 |
| 20080107731 | Kohlrausch | May 2008 | A1 |
| 20080108816 | Zutter | May 2008 | A1 |
| 20080249089 | Himmelsbach et al. | Oct 2008 | A1 |
| 20080255159 | Himmelsbach et al. | Oct 2008 | A1 |
| 20080312243 | Eckhardt et al. | Dec 2008 | A1 |
| 20080318922 | Nakahira et al. | Dec 2008 | A1 |
| 20090023920 | Eckhardt | Jan 2009 | A1 |
| 20090088408 | Meade et al. | Apr 2009 | A1 |
| 20090088569 | Eckhardt et al. | Apr 2009 | A1 |
| 20090093457 | Himmelsbach et al. | Apr 2009 | A1 |
| 20090131432 | Himmelsbach et al. | May 2009 | A1 |
| 20090137801 | Himmelsbach et al. | May 2009 | A1 |
| 20090192314 | Pfrengle et al. | Jul 2009 | A1 |
| 20090325926 | Himmelsbach | Dec 2009 | A1 |
| 20100173916 | Himmelsbach et al. | Jul 2010 | A1 |
| 20100183531 | Johncock et al. | Jul 2010 | A1 |
| 20100204250 | Himmelsbach et al. | Aug 2010 | A1 |
| 20110046076 | Eickelmann et al. | Feb 2011 | A1 |
| 20110065731 | Dugi et al. | Mar 2011 | A1 |
| 20110092510 | Klein et al. | Apr 2011 | A1 |
| 20110098240 | Dugi et al. | Apr 2011 | A1 |
| 20110112069 | Himmelsbach et al. | May 2011 | A1 |
| 20110144083 | Himmelsbach et al. | Jun 2011 | A1 |
| 20110144095 | Himmelsbach et al. | Jun 2011 | A1 |
| 20110190322 | Klein et al. | Aug 2011 | A1 |
| 20110195917 | Dugi et al. | Aug 2011 | A1 |
| 20110206766 | Friedl et al. | Aug 2011 | A1 |
| 20110263493 | Dugi et al. | Oct 2011 | A1 |
| 20110275561 | Graefe-Mody et al. | Nov 2011 | A1 |
| 20110301182 | Dugi | Dec 2011 | A1 |
| 20120003313 | Kohlrausch et al. | Jan 2012 | A1 |
| 20120035158 | Himmelsbach et al. | Feb 2012 | A1 |
| 20120040982 | Himmelsbach et al. | Feb 2012 | A1 |
| Number | Date | Country |
|---|---|---|
| 1123437 | May 1982 | CA |
| 2136288 | May 1995 | CA |
| 2418656 | Feb 2002 | CA |
| 2496325 | Mar 2004 | CA |
| 2496249 | Apr 2004 | CA |
| 2505389 | May 2004 | CA |
| 2508233 | Jun 2004 | CA |
| 2529729 | Dec 2004 | CA |
| 2543074 | Jun 2005 | CA |
| 2555050 | Sep 2005 | CA |
| 2556064 | Sep 2005 | CA |
| 2558067 | Oct 2005 | CA |
| 2561210 | Oct 2005 | CA |
| 2562859 | Nov 2005 | CA |
| 2576294 | Mar 2006 | CA |
| 2590912 | Jun 2006 | CA |
| 2651089 | Nov 2007 | CA |
| 101234105 | Aug 2008 | CN |
| 2 205 815 | Aug 1973 | DE |
| 2758025 | Jul 1979 | DE |
| 10109021 | Sep 2002 | DE |
| 10117803 | Oct 2002 | DE |
| 10238243 | Mar 2004 | DE |
| 102004019540 | Nov 2005 | DE |
| 102004024454 | Dec 2005 | DE |
| 102004044221 | Mar 2006 | DE |
| 0023032 | Jan 1981 | EP |
| 0149578 | Jul 1985 | EP |
| 0248634 | Dec 1987 | EP |
| 0400974 | May 1990 | EP |
| 0 389 282 | Sep 1990 | EP |
| 0399285 | Nov 1990 | EP |
| 409281 | Jan 1991 | EP |
| 0412358 | Feb 1991 | EP |
| 443983 | Aug 1991 | EP |
| 0524482 | Jan 1993 | EP |
| 0657454 | Jun 1995 | EP |
| 1054012 | Nov 2000 | EP |
| 1333033 | Aug 2003 | EP |
| 1338595 | Aug 2003 | EP |
| 1406873 | Apr 2004 | EP |
| 1500403 | Jan 2005 | EP |
| 1514552 | Mar 2005 | EP |
| 1557165 | Jul 2005 | EP |
| 1537880 | Aug 2005 | EP |
| 1586571 | Oct 2005 | EP |
| 1760076 | Mar 2007 | EP |
| 1829877 | Sep 2007 | EP |
| 1852108 | Nov 2007 | EP |
| 2143443 | Jan 2010 | EP |
| 385302 | Apr 1973 | ES |
| 2707641 | Jan 1995 | FR |
| 9003243 | May 1990 | HU |
| 9902308 | Jul 2000 | HU |
| S37-4895 | Jun 1962 | JP |
| 2003300977 | Oct 2003 | JP |
| 2006045156 | Feb 2006 | JP |
| 20070111099 | Nov 2007 | KR |
| 9107945 | Jun 1991 | WO |
| 9107945 | Jun 1991 | WO |
| 9205175 | Apr 1992 | WO |
| 9403456 | Feb 1994 | WO |
| 9402150 | Feb 1994 | WO |
| 9609045 | Mar 1996 | WO |
| 9636638 | Nov 1996 | WO |
| 9723473 | Jul 1997 | WO |
| 9807725 | Feb 1998 | WO |
| 9811893 | Mar 1998 | WO |
| 9822464 | May 1998 | WO |
| 9929695 | Jun 1999 | WO |
| 0073307 | Dec 2000 | WO |
| 0107441 | Feb 2001 | WO |
| 0152852 | Jul 2001 | WO |
| 0152825 | Jul 2001 | WO |
| 0177110 | Oct 2001 | WO |
| 0197808 | Dec 2001 | WO |
| 0202560 | Jan 2002 | WO |
| 0214271 | Feb 2002 | WO |
| 0224698 | Mar 2002 | WO |
| 02053516 | Jul 2002 | WO |
| 02068420 | Sep 2002 | WO |
| 03004496 | Jan 2003 | WO |
| 03000241 | Jan 2003 | WO |
| 03002531 | Jan 2003 | WO |
| 03024965 | Mar 2003 | WO |
| 03037327 | May 2003 | WO |
| 03057200 | Jul 2003 | WO |
| 03055881 | Jul 2003 | WO |
| 03104229 | Dec 2003 | WO |
| 03099279 | Dec 2003 | WO |
| 03099836 | Dec 2003 | WO |
| 03106428 | Dec 2003 | WO |
| 2004018467 | Mar 2004 | WO |
| 2004018468 | Mar 2004 | WO |
| 2004028524 | Apr 2004 | WO |
| 2004033455 | Apr 2004 | WO |
| 2004041820 | May 2004 | WO |
| 2004046148 | Jun 2004 | WO |
| 2004048379 | Jun 2004 | WO |
| 2004052362 | Jun 2004 | WO |
| 2004065380 | Aug 2004 | WO |
| 2004096806 | Nov 2004 | WO |
| 2004108730 | Dec 2004 | WO |
| 2005000846 | Jan 2005 | WO |
| 2005000848 | Jan 2005 | WO |
| 2004050658 | Jun 2005 | WO |
| 2005058901 | Jun 2005 | WO |
| 2005049022 | Jun 2005 | WO |
| 2005061489 | Jul 2005 | WO |
| 2005082906 | Sep 2005 | WO |
| 2005085246 | Sep 2005 | WO |
| 2005082906 | Sep 2005 | WO |
| 2005092870 | Oct 2005 | WO |
| 2005092877 | Oct 2005 | WO |
| 2005097798 | Oct 2005 | WO |
| 2004111051 | Dec 2005 | WO |
| 2005116000 | Dec 2005 | WO |
| 2005116014 | Dec 2005 | WO |
| 2005117861 | Dec 2005 | WO |
| 2006005613 | Jan 2006 | WO |
| 2006029769 | Mar 2006 | WO |
| 2006036664 | Apr 2006 | WO |
| 2006040625 | Apr 2006 | WO |
| 2006048427 | May 2006 | WO |
| 2006047248 | May 2006 | WO |
| 2006048209 | May 2006 | WO |
| 2006068163 | Jun 2006 | WO |
| 2006071078 | Jul 2006 | WO |
| 2006076231 | Jul 2006 | WO |
| 2006135693 | Dec 2006 | WO |
| 2006137085 | Dec 2006 | WO |
| 2007007173 | Jan 2007 | WO |
| 2007017423 | Feb 2007 | WO |
| 2007014886 | Feb 2007 | WO |
| 2007014895 | Feb 2007 | WO |
| 2007033350 | Mar 2007 | WO |
| 2007035355 | Mar 2007 | WO |
| 2007035665 | Mar 2007 | WO |
| 2007041053 | Apr 2007 | WO |
| 2007071738 | Jun 2007 | WO |
| 2007078726 | Jul 2007 | WO |
| 2007093610 | Aug 2007 | WO |
| 2007099345 | Sep 2007 | WO |
| 2007120702 | Oct 2007 | WO |
| 2007120936 | Oct 2007 | WO |
| 2007128721 | Nov 2007 | WO |
| 2007128724 | Nov 2007 | WO |
| 2007128761 | Nov 2007 | WO |
| 2007137107 | Nov 2007 | WO |
| 2007148185 | Dec 2007 | WO |
| 2007149797 | Dec 2007 | WO |
| 2008017670 | Feb 2008 | WO |
| 2008022267 | Feb 2008 | WO |
| 2008055870 | May 2008 | WO |
| 2008055940 | May 2008 | WO |
| 2008070692 | Jun 2008 | WO |
| 2008081205 | Jul 2008 | WO |
| 2008087198 | Jul 2008 | WO |
| 2008093878 | Aug 2008 | WO |
| 2008093882 | Aug 2008 | WO |
| 2008113000 | Sep 2008 | WO |
| 2008131149 | Oct 2008 | WO |
| 2009011451 | Jan 2009 | WO |
| 2009022007 | Feb 2009 | WO |
| 2009022008 | Feb 2009 | WO |
| 2009022010 | Feb 2009 | WO |
| 2009024542 | Feb 2009 | WO |
| 2009063072 | May 2009 | WO |
| 2009121945 | Oct 2009 | WO |
| 2009123992 | Oct 2009 | WO |
| 2009147125 | Dec 2009 | WO |
| 2010015664 | Feb 2010 | WO |
| 2010018217 | Feb 2010 | WO |
| 2010029089 | Mar 2010 | WO |
| 2010043688 | Apr 2010 | WO |
| 2010072776 | Jul 2010 | WO |
| 2010079197 | Jul 2010 | WO |
| 2010086411 | Aug 2010 | WO |
| 2010092125 | Aug 2010 | WO |
| 2010092163 | Aug 2010 | WO |
| 2010106457 | Sep 2010 | WO |
| 2010147768 | Dec 2010 | WO |
| 2011039367 | Apr 2011 | WO |
| 2011064352 | Jun 2011 | WO |
| 2011113947 | Sep 2011 | WO |
| 2011138380 | Nov 2011 | WO |
| 2011138421 | Nov 2011 | WO |
| 2011161161 | Dec 2011 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20080249089 A1 | Oct 2008 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60409312 | Sep 2002 | US | |
| 60461752 | Apr 2003 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 10639036 | Aug 2003 | US |
| Child | 12143128 | US |
